Section 50

EurekaMag PDF full texts Chapter 49,054


Merz, M. 1963: Eyelashes in the Anterior Chamber of the Eye. Klinika Oczna 33: 69-72
Jebava, R. 1961: Eyelashes as intraocular foreign bodies. Ceskoslovenska Oftalmologie 17: 24-27
Shlaifer, A. 1951: Eyelessness in cave animals. American Journal of Optometry and Archives of American Academy of Optometry 28(10): 534-543
Smith, B.C. 1965: Eyelid Complications of Cataract Surgery. International Ophthalmology Clinics 5: 123-133
Martin, I. 1963: Eyelid Conditioning and Concomitant Gsr Activity. Behaviour Research and Therapy 1: 255-265
Rokyta, R.; Zahlava, J.; Myslivecek, J. 1965: Eyelid Conditioning in Infants of Various-Intensity Stimuli. Activitas Nervosa Superior 7: 142-143
Kimble, G.A.; Pennypacker, H.S. 1963: Eyelid Conditioning in Young and Aged Subjects. Journal of Genetic Psychology 103: 283-289
Casady, D.R.; Zobal-Ratner, J.L.; Meyer, D.R. 2005: Eyelid abscess as a presenting sign of occult sinusitis. Ophthalmic Plastic and Reconstructive Surgery 21(5): 368-370
Camirand, A.é; Doucet, J.; Harris, J. 2005: Eyelid aging: the historical evolution of its management. Aesthetic Plastic Surgery 29(2): 65-73
Siqueira, M.; Joaquim, A.; Schellini, S.Artioli.; Padovani, C.Roberto.; Cruz, A.Augusto.Velasco.E. 2005: Eyelid alterations after the age of 50 years. Arquivos brasileiros de oftalmologia 68(3): 285-290
Schellini, S.A.; Zimmermann, G.P.M.; Hoyama, E.; Padovani, C.R.; Padovani, C.R.P. 2005: Eyelid alterations associated with palpebral ectropion. Arquivos Brasileiros de Oftalmologia 68(5): 619-622
Mencía-Gutiérrez, E.; Gutiérrez-Díaz, E.; Ricoy, J.R.; Sánez-Madrazo, N. 2004: Eyelid and cutaneous lesions as the sole indicators of tuberous sclerosis. Archivos de la Sociedad Espanola de Oftalmologia 79(8): 401-404
Scott, I.U.; McCabe, C.M.; Murray, T.G.; Rosa, R.H.; Toledano, S.; Markoe, A.M. 2003: Eyelid and scleral necrosis following bare iridium-192 seed for retinoblastoma. Ophthalmic Surgery Lasers and Imaging: the Official Journal of the International Society for Imaging in the Eye 34(4): 324-326
Shields, D.C.; Lam, S.; Gorgulho, A.; Emerson, J.; Krahl, S.E.; Malkasian, D.; DeSalles, A.A.F. 2006: Eyelid apraxia associated with subthalamic nucleus deep brain stimulation. Neurology 66(9): 1451-1452
Barnes, E.A.; Dickinson, A.J.; Langtry, J.A.A.; Lawrence, C.M. 2006: Eyelid basal cell carcinoma. British Journal of Ophthalmology 90(7): 926; Author Reply 926-7
Belisario, J.C. 1959: Eyelid carcinoma. Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 10: 68-72
Varsori, M.; Dettwiler, S.; Chaloupka, K. 2007: Eyelid chondroid syringoma: a case report. Journal Francais d'Ophtalmologie 30(1): E3
Singer, R.R. 1956: Eyelid coloboma with cutaneocorneal bridge. A.M.A. Archives of Ophthalmology 56(3): 449-450
Baron, M.R.; Connor, J.P. 1960: Eyelid conditioned responses with various levels of anxiety. Journal of Experimental Psychology 60: 310-313
Field, J.G.; Brengelmann, J.C. 1961: Eyelid conditioning and three personality parameters. Journal of Abnormal and Social Psychology 63: 517-523
Walker, E.G. 1960: Eyelid conditioning as a function of intensity of conditioned and unconditioned stimuli. Journal of Experimental Psychology 59: 303-311
Mcallister, W.R. 1953: Eyelid conditioning as a function of the CS-US interval. Journal of Experimental Psychology 45(6): 417-422
Prokasy, W.F.; Grant, D.A.; Myers, N.A. 1958: Eyelid conditioning as a function of unconditioned stimulus intensity and intertrial interval. Journal of Experimental Psychology 55(3): 242-246
Ross, L.E.; Spence, K.W. 1960: Eyelid conditioning performance under partial reinforcement as a function of UCS intensity. Journal of Experimental Psychology 59: 379-382
Drewa, T.; Krawczyk, A.; Gałazka, P.ła.; Kałuzny, J.; Sir, J. 2006: Eyelid conjunctiva can be a potential cells source for conjunctival sack reconstruction purpose. Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 20(117): 333-336
Rodríguez, N.A.; Abarzuza, R.; Cristóbal, J.A.; Sierra, J.; Mínguez, E.; Del Buey, M.A. 2006: Eyelid contact allergic eczema caused by topical ketorolac tromethamine 0.5%. Archivos de la Sociedad Espanola de Oftalmologia 81(4): 213-216
English, F.P. 2006: Eyelid contamination as a cause of endophthalmitis. Journal of Cataract and Refractive Surgery 32(3): 377-378
Abouchadi, A.; Capon-Degardin, N.; Martinot-Duquennoy, V.; Pellerin, P. 2005: Eyelid crease incision for lateral orbitotomy. Annales de Chirurgie Plastique et Esthetique 50(3): 221-227
Henke, U.; Boehncke, W.-H. 2005: Eyelid dermatitis caused by an eyelash former. Contact Dermatitis 53(4): 237
Seitz, C.S.; Bröcker, E.-B.; Trautmann, A. 2006: Eyelid dermatitis due to sodium metabisulfite. Contact Dermatitis 55(4): 249-250
Dejobert, Y.; Delaporte, E.; Piette, F.éd.ér.; Thomas, P. 2005: Eyelid dermatitis with positive patch test to coconut diethanolamide. Contact Dermatitis 52(3): 173
Ayala, F.; Fabbrocini, G.; Bacchilega, R.; Berardesca, E.; Caraffini, S.; Corazza, M.; Flori, M.L.; Francalanci, S.; Guarrera, M.; Lisi, P.; Santucci, B.; Schena, D.; Suppa, F.; Valsecchi, R.; Vincenzi, C.; Balato, N. 2003: Eyelid dermatitis: an evaluation of 447 patients. American Journal of Contact Dermatitis: Official Journal of the American Contact Dermatitis Society 14(2): 69-74
Trindade, M.A.B.; Alchorne, A.O.A.; da Costa, E.B.; Enokihara, M.M.S.S. 2004: Eyelid discoid lupus erythematosus and contact dermatitis: a case report. Journal of the European Academy of Dermatology and Venereology: Jeadv 18(5): 577-579
Ambati, B.K.; Higgins, E.; Gupta, N.; Hu, G.; Kim, T.; Carlson, A.N.; Ambati, J. 2005: Eyelid disease. Ophthalmology 112(11): 2052-2053
McCulley, J.P.; Shine, W.E. 2003: Eyelid disorders: the meibomian gland, blepharitis, and contact lenses. Eye and Contact Lens 29(1 Suppl): S93
Van Oosten, B.W.; de Langen, C.J.; Tissingh, G.; de Vries, W.A.E.J. 2004: Eyelid drooping: diagnosis on the basis of an algorithm. Nederlands Tijdschrift Voor Geneeskunde 148(36): 1753-1758
Kerschenlohr, K.; Schaller, U.C.; Messmer, E.M.; Wollenberg, A. 2003: Eyelid eczema. a therapeutic challenge. Der Ophthalmologe: Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 100(3): 240-250; Quiz 251
Zhang, H.; Hara, M.; Seki, K.; Fukuda, K.; Nishida, T. 2005: Eyelid fusion and epithelial differentiation at the ocular surface during mouse embryonic development. Japanese Journal of Ophthalmology 49(3): 195-204
Millischer-Bellaïche, A.E.; Enjolras, O.; André, C.; Bursztyn, J.; Kalifa, G.; Adamsbaum, C. 2004: Eyelid hemangiomas in infants: contribution of MRi. Journal de Radiologie 85(12 Part 1): 2019-2028
Kim, J.H.; Woo, K.I.; Chang, H.R. 2005: Eyelid incision for dacryocystorhinostomy in Asians. Korean Journal of Ophthalmology: Kjo 19(4): 243-246
Oguz, H.; Kilic, A. 2006: Eyelid infection. Ophthalmology 113(10): 1891.E1-3
Neumann, E.; Gratz, N.G. 1962: Eyelid infestation by Armillifer armillatus. American Journal of Ophthalmology 54: 305-307
Serin, D.; Parlak, A.H.; Alagöz, G.ür.; Boran, C.; Göksügür, N. 2005: Eyelid involvement in acanthosis nigricans: the importance of systemic screening. Ophthalmic Plastic and Reconstructive Surgery 21(5): 403-404
Pandhi, D.; Singal, A.; Rohtagi, J. 2006: Eyelid involvement in disseminated chronic cutaneous lupus erythematosus. Indian Journal of Dermatology Venereology and Leprology 72(5): 370-372
Cruz, A.A.V.; Zenha, F.; Silva, J.T.; Martinez, R. 2004: Eyelid involvement in paracoccidioidomycosis. Ophthalmic Plastic and Reconstructive Surgery 20(3): 212-216
Suzuki, M.; Minamoto, A.; Ishida, Y.; Aoki, S.; Yamane, K.; Mishima, H.K. 2004: Eyelid lengthening combined with penetrating keratoplasty for exposure keratopathy in Graves' ophthalmopathy--a case report. Hiroshima Journal of Medical Sciences 53(2): 29-31
Piskiniene, R. 2006: Eyelid malposition: lower lid entropion and ectropion. Medicina 42(11): 881-884
Schellini, S.A.; Preti, R.C.; Yamamoto, R.K.; Padovani, C.R.; Padovan, C.R.P. 2005: Eyelid measures before and after upper blepharoplasty--quantitative evaluation. Arquivos Brasileiros de Oftalmologia 68(1): 85-88
Nicoletti, Aé.G.B.; Matayoshi, S.; Santo, R.M.; Ferreira, V.R. 2004: Eyelid merkel cell carcinoma: report of three cases. Ophthalmic Plastic and Reconstructive Surgery 20(2): 117-121
Ahamed, R.; Ram, R.; Shannon, J.; Winter, R.K. 2006: Eyelid metastasis from lung carcinoma. Clinical and Experimental Ophthalmology 34(6): 609-610
Small, R.G.; Meyer, D.R. 2004: Eyelid metrics. Ophthalmic Plastic and Reconstructive Surgery 20(4): 266-267
Korosec, M.; Zidar, I.; Reits, D.; Evinger, C.; Vanderwerf, F. 2006: Eyelid movements during blinking in patients with Parkinson's disease. Movement Disorders: Official Journal of the Movement Disorder Society 21(8): 1248-1251
Esteban, A.; Traba, A.; Prieto, J. 2004: Eyelid movements in health and disease. the supranuclear impairment of the palpebral motility. Neurophysiologie Clinique 34(1): 3-15
Petrikovsky, B.M.; Kaplan, G.; Holsten, N. 2003: Eyelid movements in normal human fetuses. Journal of Clinical Ultrasound: Jcu 31(6): 299-301
Adachi, M.; Inoue, T.; Tsuneishi, S.; Takada, S.; Nakamura, H. 2005: Eyelid myoclonia with absences in monozygotic twins. Pediatrics International: Official Journal of the Japan Pediatric Society 47(3): 343-347
Joshi, C.N.; Patrick, J. 2007: Eyelid myoclonia with absences: routine EEG is sufficient to make a diagnosis. Seizure 16(3): 254-260
Bottino, C. 1954: Eyelid neoplasms of probable dysontogenetic nature: cystic epithelioma; clinical and histopathological aspects. Annali di Ottalmologia E Clinica Oculistica 80(2): 55-62
Sparing, R.; Kosinski, C.M.; Krings, T.; Schiefer, J. 2004: Eyelid oedema and headache. Lancet 364(9443): 1438
Camezind, P.; Robert, P.-Y. 2004: Eyelid pathology. La Revue du Praticien 54(12): 1371-1373
Mencía-Gutiérrez, E.; Gutiérrez-Díaz, E.; Ricoy, J.R.; Sarmiento-Torres, B. 2003: Eyelid phakomatous choristoma. European Journal of Ophthalmology 13(5): 482-485
Rubin, P.A.D. 2005: Eyelid position measurement. Ophthalmology 112(3): 524; Author Reply 524-5
Argin, M.A.; Yilmaz, A.; Arslan, E.; Keskinbora, K. 2006: Eyelid ptosis associated with an undetected foreign body and a remote entrance wound. Ophthalmic Plastic and Reconstructive Surgery 22(1): 73-75
Alves, A.Paula.Ximenes.; Holanda Filha, J.Gurgel.; Jerônimo, F.Trindade. 2005: Eyelid ptosis associated with pachydermoperiostosis: case report. Arquivos Brasileiros de Oftalmologia 68(3): 401-404
Marsaudon, E.; Kinay, N.; Destrieux, C.; Duong, T.H.; Renaud, C. 2005: Eyelid ptosis revealing a cerebral schistosomiasis. La Revue de Medecine Interne 26(7): 600-602
Herzog Neto, G.; Sebastiá, R.; Viana, G.André.Pires.; Machado, F. 2006: Eyelid reconstruction with Fricke's flap: report of two cases. Arquivos Brasileiros de Oftalmologia 69(1): 123-126
Ueda, K.; Oba, S.; Okada, M.; Hara, M.; Zen, N. 2007: Eyelid reconstruction with a composite radial forearm palmaris longus tendon flap. Journal of Plastic Reconstructive and Aesthetic Surgery: Jpras 60(3): 256-259
Jiaqi, C.; Zheng, W.; Jianjun, G. 2006: Eyelid reconstruction with acellular human dermal allograft after chemical and thermal burns. Burns: Journal of the International Society for Burn Injuries 32(2): 208-211
Verity, D.H.; Collin, J.R.O. 2004: Eyelid reconstruction: the state of the art. Current Opinion in Otolaryngology and Head and Neck Surgery 12(4): 344-348
Weiss, D.D.; Carraway, J.H. 2005: Eyelid rejuvenation: a marriage of old and new. Current Opinion in Otolaryngology and Head and Neck Surgery 13(4): 248-254
Millard, D.R. 1962: Eyelid repairs with a chondromucosal graft. Plastic and Reconstructive Surgery and the Transplantation Bulletin 30: 267-272
Yeatts, R.P.; Hoopes, P.C.; Saunders, S.S. 2004: Eyelid replantation eight months after traumatic avulsion. Ophthalmic Plastic and Reconstructive Surgery 20(5): 390-392
Wang, G.; McCulley, T.J. 2006: Eyelid retraction and incomplete eyelid closure secondary to human immunodeficiency virus-associated muscle wasting. Ophthalmic Plastic and Reconstructive Surgery 22(6): 479-480
Vainshtein, E.S. 1958: Eyelid retractor for localization of foreign bodies in the eye. Vestnik Rentgenologii i Radiologii 33(1): 79-80
Kleine-Natrop, H.E. 1957: Eyelid sacs; a clinical and nosological study. Dermatologische Wochenschrift 135(21): 521-531
Siddiqui, M.A.R.; Leslie, T.; Scott, C.; Mackenzie, J. 2005: Eyelid schwannoma in a male adult. Clinical and Experimental Ophthalmology 33(4): 412-413
Demirci, H.; Nelson, C.C.; Shields, C.L.; Eagle, R.C.; Shields, J.A. 2007: Eyelid sebaceous carcinoma associated with Muir-Torre syndrome in two cases. Ophthalmic Plastic and Reconstructive Surgery 23(1): 77-79
Lai, T.F.; Huilgol, S.C.; Selva, D.; James, C.L. 2004: Eyelid sebaceous carcinoma masquerading as in situ squamous cell carcinoma. Dermatologic Surgery: Official Publication for American Society for Dermatologic Surgery 30(2 Part 1): 222-225
Viard, P. 1955: Eyelid separation in albino rat. Archives d'Anatomie Microscopique et de Morphologie Experimentale 44(4): 344-350
Daoud, Y.J.; Foster, C.Stephen.; Ahmed, R. 2005: Eyelid skin involvement in pemphigus foliaceus. Ocular Immunology and Inflammation 13(5): 389-394
Rosner, M.; Bourla, N.; Rosen, N. 2004: Eyelid splitting and extirpation of hair follicles using a radiosurgical technique for treatment of trichiasis. Ophthalmic Surgery Lasers and Imaging: the Official Journal of the International Society for Imaging in the Eye 35(2): 116-122
Ma, J.; Zhao, J.; Bai, Q.; He, S.; Yu, J.; Gou, Y. 2018: Application of VSD in 6 Cases of Postoperative Infection
-A Clinical Experience Sharing. Zhongguo Fei Ai Za Zhi 21(4): 343-347
Pessoa de Souza Filho, Jão.; Martins, M.Cristina.; Sant'Anna, A.Estela.B.P.P.; Coutinho, A.Baptista.; Burnier, M.N.; Rigueiro, M.Pezati. 2005: Eyelid swelling as the only manifestation of ocular sarcoidosis. Ocular Immunology and Inflammation 13(5): 399-402
El-Saify, W.Magdy.; Sherkawi, E.H.; Rogers, C. 2005: Eyelid swelling: an unusual presentation of metastatic lobular carcinoma of the breast. Breast Journal 11(6): 476-477
Naik, M.N.; Raizada, K. 2006: Eyelid switch flap technique for the management of congenital anophthalmos associated with contracted socket. Ophthalmic Plastic and Reconstructive Surgery 22(6): 476-479
Santos-Bueso, E.; Calvo-González, C.; Díaz-Valle, D.; Benítez-del-Castillo, J.M.; García-Sánchez, J. 2006: Eyelid tick bite. Archivos de la Sociedad Espanola de Oftalmologia 81(3): 173-175
Mencía-Gutiérrez, E.; Gutiérrez-Díaz, E.; Ricoy, J.é R.; Rodríguez-Peralto, J.é L. 2003: Eyelid trichoblastoma: an unusual localization. International Journal of Dermatology 42(3): 201-202
Sugano, Débora.Mayumi.; Lucci, Lúcia.Miriam.Dumont.; Avila, M.Pereira.de.; Rehder, Jé.Ricardo.Carvalho.Lima.; Pettinati, J. 2005: Eyelid trichoepithelioma--report of 2 cases. Arquivos Brasileiros de Oftalmologia 68(1): 136-139
Pornpanich, K.; Chindasub, P. 2005: Eyelid tumors in Siriraj Hospital from 2000-2004. Journal of the Medical Association of Thailand 88 Suppl. 9: S11-S14
Kwitko, M.L.; Boniuk, M.; Zimmerman, L.E. 1963: Eyelid tumors with reference to lesions confused with squamous cell carcinoma. I. Incidence and errors in diagnosis. Archives of Ophthalmology 69: 693-697
De Wan, J.; Evens, F.; De Mey, A. 2005: Eyelid tumour and juvenile hyaline fibromatosis. British Journal of Plastic Surgery 58(1): 106-111
Deveer, J.A. 1952: Eyelid: chalazion. Brooklyn Hospital Journal 10(4): 243-245
Stuart, E.M. 1953: Eyes and ears in education. Canadian Hospital 30(2): 36-38
Banzato, C.E.M.; Pereira, M.E.C. 2005: Eyes and ears wide open: values in the clinical setting. World Psychiatry: Official Journal of the World Psychiatric Association 4(2): 90-91
Milán de Grado, S. 2005: Eyes and fluids in the 20th Century paintings. Archivos de la Sociedad Espanola de Oftalmologia 80(1): 53-56
Otto, H. 1957: Eyes and liver in periarteritis nodosa. Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 12(6): 244-252
Ristic, J.; Mottron, L.; Friesen, C.K.; Iarocci, G.; Burack, J.A.; Kingstone, A. 2005: Eyes are special but not for everyone: the case of autism. Brain Research. Cognitive Brain Research 24(3): 715-718
Sopott-Ehlers, B.; Ehlers, U. 2003: Eyes covered by mitochondrial lenses in Petaliella spiracauda and Ptychopera purasjokii (Plathelminthes, Rhabdocoela, Trigonostominae). Ultrastructural features and phylogenetic implications. Journal of Submicroscopic Cytology and Pathology 35(4): 415-421
Carpenter, E.M. 1954: Eyes for the fourth. Nursing Outlook 2(8): 406-407
Knüppel, J. 2003: Eyes here and there. Pflege Aktuell 57(7-8): 371
Svec, V.; Vykydal, M.; Jorda, V. 1961: Eyes in antimalarial therapy. Casopis Lekaru Ceskych 100: 1451-1454
Bilotta, D.E. 2000: Eyes in the back of my head: unobtrusive student evaluation. Nurse Educator 25(6): 266
Conn, J. 2007: Eyes on the EHR. Clinical systems, cost issues also among priorities. Modern Healthcare 37(9): 37-38
Clark, J.J. 2006: Eyes on the supplies: results of a massive performance improvement initiative. Healthcare Financial Management: Journal of the Healthcare Financial Management Association 60(4): 74-82
Marx, E.; Deutschländer, A.; Stephan, T.; Dieterich, M.; Wiesmann, M.; Brandt, T. 2004: Eyes open and eyes closed as rest conditions: impact on brain activation patterns. Neuroimage 21(4): 1818-1824
Balzer, K. 2005: Eyes open!. Pflege Zeitschrift 58(9): 539
Gheorghiade, M. 2006: The clinical effects of vasopressin receptor antagonists in heart failure. Cleveland Clinic Journal of Medicine 73 Suppl 2(3): S24
Chen, I. 2003: Eyes wide open. Science of Aging Knowledge Environment: Sage Ke 2003(42): Nf19
Hoosein, S. 2006: Eyes wide open: the awake craniotomy for tumour resection: a review. Axone 28(1): 15-18
Harrison, S. 2003: Eyes wide shut. Nursing Standard: 1987) 17(30): 12-13
Fischer, B.; Rehm, J.ür.; Kim, G.; Kirst, M. 2005: Eyes wide shut?--A conceptual and empirical critique of methadone maintenance treatment. European Addiction Research 11(1): 1-9; Discussion: 10-14
Trampusch, H.A.L. 1951: Eyes with feet, feet with lenses and other peculiarities. Nederlands Tijdschrift Voor Geneeskunde 95(34): 2498-2504
Granstrom, K.O. 1952: Eyes with normal visual acuity without glasses; an analytical study. Acta Ophthalmologica 30(1): 107-114
Gigson, S. 1954: Eyes, ears and hands in diagnosis of congenital heart diseases. Archivos de Pediatria del Uruguay 25(10): 711-712
Gibson, S. 1954: Eyes, hands and ears in the diagnosis of heart disease in children. Pediatric Clinics of North America 1954: 3-12
Rundal'tseva, N.N. 1955: Eyesight in kindergarten children doing ocular work. Gigiena i Sanitariia 11: 28-32
Rehder, B.; Hoffman, A.B. 2005: Eyetracking and selective attention in category learning. Cognitive Psychology 51(1): 1-41
Hwang, Y-Shiou.; Chen, S-Ni.; Chao, A-Ning. 2002: Eyewall resection for a uveal malignant melanoma under local anesthesia. Chang Gung Medical Journal 25(12): 850-853
Robinson, P.V. 1951: Eyewear and art. Optical Journal and Review of Optometry 88(4): 46
Smith, S. 1963: Eyewear the child will wear. Optometric Weekly 54: 200-201
Steblay, N.; Dysart, J.; Fulero, S.; Lindsay, R.C. 2003: Eyewitness accuracy rates in police showup and lineup presentations: a meta-analytic comparison. Law and Human Behavior 27(5): 523-540
Meissner, C.A.; Tredoux, C.G.; Parker, J.F.; MacLin, O.H. 2005: Eyewitness decisions in simultaneous and sequential lineups: a dual-process signal detection theory analysis. Memory and Cognition 33(5): 783-792
Brewer, N.; Caon, A.; Todd, C.; Weber, N. 2006: Eyewitness identification accuracy and response latency. Law and Human Behavior 30(1): 31-50
Weber, N.; Brewer, N.; Wells, G.L.; Semmler, C.; Keast, A. 2004: Eyewitness identification accuracy and response latency: the unruly 10-12-second rule. Journal of Experimental Psychology. Applied 10(3): 139-147
Ericson, K.; Isaacs, B. 2003: Eyewitness identification accuracy: a comparison of adults with and those without intellectual disabilities. Mental Retardation 41(3): 161-173
Charman, S.D.; Wells, G.L. 2007: Eyewitness lineups: is the appearance-change instruction a good idea?. Law and Human Behavior 31(1): 3-22
Henry, L.A.; Gudjonsson, G.H. 2003: Eyewitness memory, suggestibility, and repeated recall sessions in children with mild and moderate intellectual disabilities. Law and Human Behavior 27(5): 481-505
Memon, A.; Hope, L.; Bartlett, J.; Bull, R. 2002: Eyewitness recognition errors: the effects of mugshot viewing and choosing in young and old adults. Memory and Cognition 30(8): 1219-1227
Kelloway, E.Kevin.; Stinson, V.; MacLean, C. 2004: Eyewitness testimony in occupational accident investigations: towards a research agenda. Law and Human Behavior 28(1): 115-132
Granhag, Pär.Anders.; Strömwall, L.A.; Hartwig, M. 2005: Eyewitness testimony: tracing the beliefs of Swedish legal professionals. Behavioral Sciences and the Law 23(5): 709-727
Souba, W.W.; Copeland, E.M. 2003: Eyewitness to leadership. American Surgeon 69(1): 56-58
Terol Figuerola, J.A. 1953: Eyries surgical technic in therapy of ozena; results of three years of experimentation. Medicamenta 11(232): 175-178
Venclik, H. 1956: Eyries' operation of ozena. Ceskoslovenska Otolaryngologie 5(1): 32-34
Schuldberg, D. 2005: Eysenck Personality Questionnaire scales and paper-and-pencil tests related to creativity. Psychological Reports 97(1): 180-182
Hamilton, V. 1959: Eysenck' s theories of anxiety and hysteria; a methodological critique. British Journal of Psychology 50(1): 48-63
Argyle, M. 1965: Eysenck's Theory of the Conscience: a Reply. British Journal of Psychology 56: 309-310
Storms, L.H.; Sigal, J.J. 1958: Eysenck's personality theory with special reference to the dynamics of anxiety and hysteria. British Journal of Medical Psychology 31(3-4): 228-246
Rokeach, M.; Hanley, C. 1956: Eysenck's tender-mindedness dimension: a critique. Psychological Bulletin 53(2): 169-176
Christie, R. 1956: Eysenck's treatment of the personality of communists. Psychological Bulletin 53(6): 411-430
Franks, C.M.; Holden, E.A.; Phillips, M. 1961: Eysenck's "stratification" theory and the questionnaire method of measuring personality. Journal of Clinical Psychology 17: 248-253
Meyer Zu Schwabedissen, H.; Kroemer, H.K. 2004: Ezetimib. Deutsche Medizinische Wochenschrift 129(39): 2038-2040
Anonymous 2005: Ezetimib and simvastatin. Cooperation at receptors of cholesterol metabolism. MMWFortschrittederMedizin 147(27-28): 50
Sudhop, T.; von Bergmann, K. 2003: Ezetimib as combination partner in hypercholesteremia. Lowering LDL beyond the effect of statins. MMW Fortschritte der Medizin 145(16): 48-50
Kvapil, M. 2004: Ezetimib--a new possibility for combined therapy in hypercholesterolemia. Vnitrni Lekarstvi 50(8): 643-644
Susekov, A.V. 2005: Ezetimib--inhibitor of cholesterol absorption: new perspectives in the treatment of dyslipidemia. Terapevticheskii Arkhiv 77(8): 24-29
Harris, M.; Davis, W.; Brown, W.Virgil. 2003: Ezetimibe. Drugs of Today 39(4): 229-247
Scheen, A.J. 2004: Ezetimibe (Ezetrol). Revue Medicale de Liege 59(4): 246-250
Patel, J.; Sheehan, V.; Gurk-Turner, C. 2003: Ezetimibe (Zetia): a new type of lipid-lowering agent. Proceedings 16(3): 354-358
Flores, N.A. 2004: Ezetimibe + simvastatin (Merck/Schering-Plough). Current Opinion in Investigational Drugs 5(9): 984-992
Denke, M.; Pearson, T.; McBride, P.; Gazzara, R.A.; Brady, W.E.; Tershakovec, A.M. 2006: Ezetimibe added to ongoing statin therapy improves LDL-C goal attainment and lipid profile in patients with diabetes or metabolic syndrome. Diabetes and Vascular Disease Research 3(2): 93-102
Bronson, D.L. 2003: Ezetimibe added to ongoing statin therapy reduced LDL cholesterol in primary hypercholesterolemia. Acp Journal Club 139(1): 8
Simons, L.A.; Symons, J. 2007: Ezetimibe added to statin therapy (EASY study) - an evaluation by Australian general practitioners. AustralianFamilyPhysician 36(1-2): 90
Lavoie, M.-A.é 2003: Ezetimibe and cholesterol absorption. Canadian Journal of Clinical Pharmacology 10 Suppl A: 7a
Lindberg, M. 2005: Ezetimibe and safety. Ugeskrift for Laeger 167(7): 785-786
Fux, R.; Mörike, K.; Gundel, U.-F.; Hartmann, R.üd.; Gleiter, C.H. 2004: Ezetimibe and statin-associated myopathy. Annals of Internal Medicine 140(8): 671-672
Borja, J. 2005: Ezetimibe coadministered with fenofibrate: some safety questions. European Heart Journal 26(21): 2344; Author Reply 2344
Morris, S.; Tiller, R. 2003: Ezetimibe for hypercholesterolemia. American Family Physician 68(8): 1595-1596
Husereau, D.R. 2003: Ezetimibe for lowering blood cholesterol. Issues in Emerging Health Technologies 49: 1-4
Kohnle, M.; Pietruck, F.; Kribben, A.; Philipp, T.; Heemann, U.; Witzke, O. 2006: Ezetimibe for the treatment of uncontrolled hypercholesterolemia in patients with high-dose statin therapy after renal transplantation. American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 6(1): 205-208
Anonymous 2005: Ezetimibe offers new opportunity to lower LDL-C to target levels. Cardiovascular journal of South Africa: official journal for Southern Africa Cardiac Society and South African Society of Cardiac Practitioners 16(3): 174
Madigosky, W.S.; Kane, K.Y. 2003: Ezetimibe plus atorvastatin lowers cholesterol. Journal of Family Practice 52(9): 671-672
Bronson, D.L. 2005: Ezetimibe plus simvastatin lowered lipid levels more than simvastatin monotherapy in primary hypercholesterolemia. Acp Journal Club 142(1): 16
Jublanc, C.; Giral, P.; Turpin, G.ér. 2006: Ezetimibe with statins. Presse Medicale 35(3 Part 2): 487-494
Sebei, P.J.; McCrindle, C.M.E.; Green, E.D.; Turner, M.L. 2004: Use of scanning electron microscopy to confirm the identity of lice infesting communally grazed goat herds. Onderstepoort Journal of Veterinary Research 71(2): 87-92
Pikto-Pietkiewicz, W.; Pasierski, T. 2006: Ezetimibe--intestinal cholesterol absorbtion inhibitor. Kardiologia Polska 64(12): 1434-1441
Araújo, R.G.; Casella Filho, A.; Chagas, A.C.P. 2005: Ezetimibe--pharmacokinetics and therapeutics. Arquivos Brasileiros de Cardiologia 85(Suppl 5): 20-24
Doherty, E.; Lumb, P.J.; Chik, G.; Wierzbicki, A.S. 2005: Ezetimibe-induced hyperlipidaemia. International Journal of Clinical Practice. Suppl 147: 3-5
Goldman-Levine, J.D.; Bohlman, L.G. 2005: Ezetimibe/Simvastatin (vytorin) for hypercholesterolemia. American Family Physician 72(10): 2081-2082
Murdoch, D.; Scott, L.J. 2004: Ezetimibe/Simvastatin: a review of its use in the management of hypercholesterolemia. American Journal of Cardiovascular Drugs: Drugs Devices and other Interventions 4(6): 405-422
Kastelein, J.J.P.; Sankatsing, R.R. 2005: Ezetimibe/simvastatin (INEGY) in the treatment of hyperlipidaemia. International Journal of Clinical Practice 59(12): 1464-1471
Daskalopoulou, S.S.; Mikhailidis, D.P. 2006: Ezetimibe/simvastatin single tablet versus rosuvastatin in patients with hypercholesterolemia. Current Medical Research and Opinion 22(10): 2037-2039
Wierzbicki, A.S. 2003: Ezetimibe: a new addition to lipid-lowering therapy. International Journal of Clinical Practice 57(8): 653-655
Patel, S.B. 2004: Ezetimibe: a novel cholesterol-lowering agent that highlights novel physiologic pathways. Current cardiology reports 6(6): 439-442
Davidson, M.H. 2003: Ezetimibe: a novel option for lowering cholesterol. Expert Review of Cardiovascular Therapy 1(1): 11-21
Kosoglou, T.; Statkevich, P.; Johnson-Levonas, A.O.; Paolini, J.F.; Bergman, A.J.; Alton, K.B. 2005: Ezetimibe: a review of its metabolism, pharmacokinetics and drug interactions. Clinical Pharmacokinetics 44(5): 467-494
Lee, S. 2005: Ezetimibe: a turbocharger for the race to reach NCEP LDL goals. South Dakota Journal of Medicine 58(10): 435-436
Yang, Z.; Tian, S.; Liu, L.; Wang, X.; Zhang, Z. 2018: Application of washed MSWi fly ash in cement composites: long-term environmental impacts. Environmental Science and Pollution Research International 25(12): 12127-12138
Anonymous 2004: Ezetimibe: new preparation. A cholesterol-lowering drug with no clinical advantage. Prescrire International 13(73): 176-179
Yatskar, L.; Fisher, E.A.; Schwartzbard, A. 2006: Ezetimibe: rationale and role in the management of hypercholesterolemia. Clinical Cardiology 29(2): 52-55
Petrica, S.C.; Phillips, B. 2005: Ezra Griffith's biographical note about Bob Phillips. Journal of the American Academy of Psychiatry and the Law 33(4): 565
Rogers, F.B.; Hunt, E.M. 1956: Ezra Mundy Hunt: 1830-1894; pioneer of public health. Journal of the Medical Society of New Jersey 53(11): 554-558
Simonov, P.V.; Asratian, E.Asatovich. 2003: Ezras Asratovich Asratian (1903-1981). Zhurnal vysshei nervnoi deiatelnosti imeni I P Pavlova 53(3): 261-263
Stanasila, L.; Abuin, L.; Diviani, D.; Cotecchia, S. 2006: Ezrin directly interacts with the alpha1b-adrenergic receptor and plays a role in receptor recycling. Journal of Biological Chemistry 281(7): 4354-4363
Kim, M.S.; Song, W.S.; Cho, W.H.; Lee, S.-Y.; Jeon, D.-G. 2007: Ezrin expression predicts survival in stage IIB osteosarcomas. Clinical Orthopaedics and Related Research 459: 229-236
Gimeno, L.; Corradi, A.; Cobos, I.; Consalez, G.G.; Martinez, S. 2004: Ezrin gene, coding for a membrane-cytoskeleton linker protein, is regionally expressed in the developing mouse neuroepithelium. Gene Expression Patterns: Gep 4(6): 749-754
Cai, Z.-d.; Li, G.-d. 2005: Ezrin protein: novel hot point of research on mechanism of neoplasm metastasis. Zhonghua Zhong Liu Za Zhi 27(6): 322-325
Ostalska-Nowicka, D.; Zachwieja, J.; Nowicki, M.; Kaczmarek, E.; Siwinska, A.; Witt, M. 2006: Ezrin--a useful factor in the prognosis of nephrotic syndrome in children: an immunohistochemical approach. Journal of Clinical Pathology 59(9): 916-920
Curto, M.; McClatchey, A.I. 2004: Ezrin...a metastatic detERMinant?. Cancer Cell 5(2): 113-114
Staudinger, H.; Ullrich, V. 1964: Ezymatic Hydroxylase Models. Biochemische Zeitschrift 339: 491-497
Aykroyd, W.R. 1953: F a O. Nutrition Abstracts and Reviews 23(2): 229-243
Gaito, J. 1964: F and T Tests Relative to One- and Two-Tailed Tests. Journal of General Psychology 71: 131-134
Siddiqi, O.; Crick, F.H.C. 2004: F H C Crick (1916 - 2004). Journal of Biosciences 29(4): 375-377
Schroeder, S.L.M.; Weiher, N. 2006: F K-edge X-ray absorption near-edge structure (XANES) of AlF3 polymorphs: combining ab initio calculations with Walsh correlation diagrams. Physical Chemistry Chemical Physics: Pccp 8(15): 1807-1811
Parisot, D.; Malet-Martino, M.C.; Martino, R.; Crasnier, P. 1991: F Nuclear Magnetic Resonance Analysis of 5-Fluorouracil Metabolism in Four Differently Pigmented Strains of Nectria haematococca. Applied and Environmental Microbiology 57(12): 3605-3612
Kozhevnikov, G.N.; Trushin, N.I.; Gusarov, F.V. 1972: F V Gusarov--A physician revolutionary. Sovetskoe Zdravookhranenie 31(12): 68-73
Takahata, N.; Nei, M. 1984: F and g statistics in the finite island model. Genetics 107(3): 501-504
Islam, M.R.; Bhowmik, N.B.; Haque, A.; Haque, S.; Haque, A.; Rahman, H.R. 2005: F wave latency--a frequent and early involved nerve conduction parameter in young diabetic subjects. Mymensingh Medical Journal: Mmj 14(1): 46-49
Bal, S.; Celiker, R.; Palaoglu, S.çu.; Cila, A.şe. 2006: F wave studies of neurogenic intermittent claudication in lumbar spinal stenosis. American Journal of Physical Medicine and Rehabilitation 85(2): 135-140
Doutre, L.P.; Masse, C.; Papin, F'ELIX. 1963: F'elix Papin (1888-1963). Bordeaux chirurgical 2: 55-56
Stewart-Pullaro, J.; Daugomah, J.W.; Chestnut, D.E.; Graves, D.A.; Sobsey, M.D.; Scott, G.I. 2006: F+ RNA coliphage typing for microbial source tracking in surface waters. Journal of Applied Microbiology 101(5): 1015-1026
Gómez-Carrasco, S.; Roncero, O.; González-Sánchez, L.; Hernández, M.L.; Alvariño, J.é M.; Paniagua, M.; Aguado, A. 2005: F+OH reactive collisions on new excited 3A" and 3A' potential-energy surfaces. Journal of Chemical Physics 123(11): 114310
Hsieh, H.-J.; Lin, S.-H.; Chu, Y.-K.; Chang, C.-P.; Liu, R.-S. 2004: F-18 FDG PET and Ga-67 scintigraphy in a case of fever of unknown origin with underlying cutaneous diffuse large B-Cell lymphoma. Clinical Nuclear Medicine 29(12): 859-860
Shih, W.-J.; Huang, W.-S.; Milan, P.P. 2006: F-18 FDG PET demonstrates crossed cerebellar diaschisis 20 years after stroke. Clinical Nuclear Medicine 31(5): 259-261
Nguyen, B.D. 2003: F-18 FDG PET demonstration of sclerosing mesenteritis. Clinical Nuclear Medicine 28(8): 670-671
Nguyen, B.D. 2005: F-18 FDG PET demonstration of thyroglossal duct cyst. Clinical Nuclear Medicine 30(6): 411-413
Iagaru, A.; Mari, C.; Segall, G. 2006: F-18 FDG PET evaluation of bronchial plasmacytoma with CT and MRi correlation. Clinical Nuclear Medicine 31(5): 279-280
Zaknun, J.J.; Kendler, D.; Moncayo, R.; zur Nedden, D.; Virgolini, I. 2005: F-18 FDG PET for assessing tyrosine kinase-related signal transduction inhibition in a GIST c-kit-positive tumor patient by imatinib. Clinical Nuclear Medicine 30(11): 749-751
Gupta, P.; Kramer, E.; Ponzo, F.; Su, H. 2004: F-18 FDG PET imaging features of a perigraft leak and thrombus in a patient with dissecting descending thoracic aortic aneurysm. Clinical Nuclear Medicine 29(11): 750-751
Watanabe, N.; Kawano, M.; Takada, M.; Iwamoto, S.; Shimizu, M.; Kawabe, H.; Kamisaki, Y.; Noguchi, K.; Seto, H. 2006: F-18 FDG PET imaging in a primitive neuroectodermal tumor. Clinical Nuclear Medicine 31(8): 484-485
Watanabe, N.; Kato, H.; Shimizu, M.; Murakami, J.; Kawabe, H.; Kamisaki, Y.; Kageyama, M.; Matsunari, I.; Hisada, K.; Seto, H. 2006: F-18 FDG PET imaging in gastric neuroendocrine carcinoma. Clinical Nuclear Medicine 31(6): 345-346
Reddy, M.P.; Reddy, P.; Lilien, D.L. 2003: F-18 FDG PET imaging in gastrointestinal stromal tumor. Clinical Nuclear Medicine 28(8): 677-679
Nguyen, B.D. 2007: F-18 FDG PET imaging of disseminated sarcoidosis. Clinical Nuclear Medicine 32(1): 53-54
Nguyen, B.D. 2005: F-18 FDG PET imaging of metastases from soft tissue myoepithelioma. Clinical Nuclear Medicine 30(3): 201-202
Iagaru, A.; Gamie, S.; Segall, G. 2006: F-18 FDG PET imaging of urinary bladder oat cell carcinoma with widespread osseous metastases. Clinical Nuclear Medicine 31(8): 476-478
Ak, I.; Can, C. 2005: F-18 FDG PET in detecting renal cell carcinoma. Acta Radiologica 46(8): 895-899
Diehl, M.; Graichen, S.; Menzel, C.; Lindhorst, E.; Grünwald, F. 2003: F-18 FDG PET in insular thyroid cancer. Clinical Nuclear Medicine 28(9): 728-731
Win, Z.; O'Flynn, E.; O'Rourke, E.J.; Singh, A.; Cooke, G.S.; Friedland, J.S.; Al-Nahhas, A. 2006: F-18 FDG PET in the diagnosis and monitoring of salmonella vertebral osteomyelitis: a comparison with MRi. Clinical Nuclear Medicine 31(7): 437-440
Malhotra, G.; Nair, N.; Awasare, S. 2006: F-18 FDG PET scan findings in a case of carcinoma of the breast with a rare site of metastases to the gingival region. Clinical Nuclear Medicine 31(12): 820-821
Su, H.-Y.; Liu, R.-S.; Liao, S.-Q.; Wang, S.-J. 2006: F-18 FDG PET superscan. Clinical Nuclear Medicine 31(1): 28-29
Iagaru, A.; Gamie, S.; Segall, G. 2007: F-18 FDG PET visualization of urinary leak after nephrostomy tube removal. Clinical Nuclear Medicine 32(2): 168-169
Luthra, K.; Shah, S.; Purandare, N.; Medhi, S.; Rangarajan, V.; Samuel, A.M. 2006: F-18 FDG PET-CT appearance of metastatic brachial plexopathy in a case of carcinoma of the breast. Clinical Nuclear Medicine 31(7): 432-434
Koshy, M.; Paulino, A.C.; Howell, R.; Schuster, D.; Halkar, R.; Davis, L.W. 2005: F-18 FDG PET-CT fusion in radiotherapy treatment planning for head and neck cancer. Head and Neck 27(6): 494-502
Davison, J.M.; Montilla-Soler, J.L.; Broussard, E.; Wilson, R.; Cap, A.; Allen, T. 2005: F-18 FDG PET-CT imaging of a mycotic aneurysm. Clinical Nuclear Medicine 30(7): 483-487
Iagaru, A.; McDougall, I.R. 2007: F-18 FDG PET/CT demonstration of an adrenal metastasis in a patient with anaplastic thyroid cancer. Clinical Nuclear Medicine 32(1): 13-15
Iagaru, A.; Quon, A.; McDougall, I.R.; Gambhir, S.S. 2006: F-18 FDG PET/CT evaluation of osseous and soft tissue sarcomas. Clinical Nuclear Medicine 31(12): 754-760
Niederkohr, R.D.; Dadras, S.S.; Leavitt, M.; McDougall, I.R. 2007: F-18 FDG PET/CT imaging of a subcutaneous scalp metastasis from primary carcinoma of the thyroid. Clinical Nuclear Medicine 32(2): 162-164
Nguyen, B.D.; Ram, P.C.; Roarke, M.C. 2007: F-18 FDG PET/CT imaging of anal canal squamous cell carcinoma. Clinical Nuclear Medicine 32(3): 234-236
Nguyen, B.D. 2006: F-18 FDG PET/CT imaging of disseminated coccidioidomycosis. Clinical Nuclear Medicine 31(9): 568-571
Niederkohr, R.D.; Gambhir, S.S. 2006: F-18 FDG PET/CT imaging of extramammary Paget disease of the perianal region. Clinical Nuclear Medicine 31(9): 561-563
Jacene, H.A.; Cohade, C.; Wahl, R.L. 2004: F-18 FDG PET/CT in acute respiratory distress syndrome: a case report. Clinical Nuclear Medicine 29(12): 786-788
Nguyen, B.D.; Roarke, M.C.; Nelson, K.D.; Chong, B.W. 2006: F-18 FDG PET/CT staging and posttherapeutic assessment of esthesioneuroblastoma. Clinical Nuclear Medicine 31(3): 172-174
Vento, J.A.; Arici, M.; Spencer, R.P.; Sood, R. 2004: F-18 FDG PET: mottled splenomegaly with remission of symptoms after splenectomy in sarcoidosis. Clinical Nuclear Medicine 29(2): 103-104
Hsieh, H.-J.; Lin, S.-H.; Chu, Y.-K.; Chang, C.-P.; Wang, S.-J. 2005: F-18 FDG and F-18 FDOPA PET brain imaging in subacute sclerosing panencephalitis. Clinical Nuclear Medicine 30(7): 519-520
Liu, H.-G.; Mountz, J.M. 2003: F-18 FDG brain positron emission tomography and Tl-201 early and delayed SPECT in distinguishing atypical cerebral tumor from cerebral infarction. Clinical Nuclear Medicine 28(3): 241-242
Hurwitz, R. 2003: F-18 FDG positron emission tomographic imaging in a case of ruptured breast implant: inflammation or recurrent tumor?. Clinical Nuclear Medicine 28(9): 755-756
Shon, I.H.; Fogelman, I. 2003: F-18 FDG positron emission tomography and benign fractures. Clinical Nuclear Medicine 28(3): 171-175
Jain, M.; Yung, E.; Trow, T.; Katz, D.S. 2004: F-18 FDG positron emission tomography demonstration of pulmonary carcinoid. Clinical Nuclear Medicine 29(6): 370-371
Yoon, S.-N.; Lee, M.-H.; Yoon, J.-K. 2004: F-18 FDG positron emission tomography findings in primary pancreatic lymphoma. Clinical Nuclear Medicine 29(9): 574-575
Williams, H.T.; Gossage, J.R.; Allred, T.J.; Kallab, A.M.; Pancholy, A.; Anstadt, M.P. 2004: F-18 FDG positron emission tomography imaging of rare soft tissue sarcomas: low-grade fibromyxoid sarcoma and malignant hemangiopericytoma. Clinical Nuclear Medicine 29(9): 581-584
Kumar, R.; Xiu, Y.; Dhurairaj, T.; Yu, J.Q.; Alavi, A.; Zhuang, H. 2005: F-18 FDG positron emission tomography in non-Hodgkin lymphoma of the breast. Clinical Nuclear Medicine 30(4): 246-248
Patrikeos, A.; Breidahl, W.; Robins, P. 2005: F-18 FDG uptake associated with Elastofibroma dorsi. Clinical Nuclear Medicine 30(9): 617-618
Hara, M.; Kume, M.; Oshima, H.; Shibamoto, Y.; Iida, A.; Mori, Y.; Nakamura, A.; Murase, T. 2005: F-18 FDG uptake in a malignant localized fibrous tumor of the pleura. Journal of Thoracic Imaging 20(2): 118-119
Allen, S.; Todd, J.; Copley, S.; Al-Nahhas, A. 2005: F-18 FDG uptake in bilateral pulmonary artery leiomyosarcomata, one mimicking a pulmonary embolus. Clinical Nuclear Medicine 30(6): 418-419
Goerres, G.W.; Forster, A.; Uebelhart, D.; Seifert, B.; Treyer, V.; Michel, B.; von Schulthess, G.K.; Kaim, A.H. 2006: F-18 FDG whole-body PET for the assessment of disease activity in patients with rheumatoid arthritis. Clinical Nuclear Medicine 31(7): 386-390
Hernandez-Pampaloni, M.; Takalkar, A.; Yu, J.Q.; Zhuang, H.; Alavi, A. 2006: F-18 FDG-PET imaging and correlation with CT in staging and follow-up of pediatric lymphomas. Pediatric Radiology 36(6): 524-531
Diederichs, C.G..; Staib, L.; Glasbrenner, B.; Guhlmann, A.; Glatting, G.; Pauls, S.; Beger, H.G.; Reske, S.N. 1999: F-18 Fluorodeoxyglucose (FDG) and C-Reactive Protein (CRP). Clinical Positron Imaging: Official Journal of the Institute for Clinical P.E.T 2(3): 131-136
Jong, I.; Ramdave, S.; Lau, E.; Binns, D.; Hicks, R. 2004: F-18 PET soft tissue uptake in seatbelt injury. Clinical Nuclear Medicine 29(12): 809-810
Zhang, W.; Oya, S.; Kung, M.-P.; Hou, C.; Maier, D.L.; Kung, H.F. 2005: F-18 Polyethyleneglycol stilbenes as PET imaging agents targeting Abeta aggregates in the brain. Nuclear Medicine and Biology 32(8): 799-809
Vasanawala, M.S.; Wang, Y.; Quon, A.; Gambhir, S.S. 2006: F-18 fluorodeoxyglucose PET/CT as an imaging tool for staging and restaging cutaneous angiosarcoma of the scalp. Clinical Nuclear Medicine 31(9): 534-537
Nguyen, J.D.; Dunleavy, K.; Carrasquillo, J.A.; Chen, C.C. 2004: F-18 fluorodeoxyglucose positron emission tomographic imaging in a patient with persistent hiccups. Clinical Nuclear Medicine 29(1): 35-36
Mackie, G.C. 2004: F-18 fluorodeoxyglucose positron emission tomographic imaging of cytomegalovirus pneumonia. Clinical Nuclear Medicine 29(9): 569-571
Miyake, M.; Tateishi, U.; Maeda, T.; Arai, Y.; Seki, K.; Hasegawa, T.; Sugimura, K. 2006: F-18 fluorodeoxyglucose positron emission tomography finding of Mazabraud syndrome. Clinical Nuclear Medicine 31(10): 627-629
Hsu, C.-H.; Lee, C.-M.; Chia, C.-F.; Lin, Y.-H. 2004: F-18 fluorodeoxyglucose positron emission tomography in an anorectal fistula with actinomycosis. Clinical Nuclear Medicine 29(7): 452-453
Hsu, C.-H.; Lee, C.-M.; Wang, F.-C.; Lin, Y.-H. 2003: F-18 fluorodeoxyglucose positron emission tomography in pulmonary cryptococcoma. Clinical Nuclear Medicine 28(9): 791-793
Majhail, N.S.; Urbain, J.-L.; Albani, J.M.; Kanvinde, M.H.; Rice, T.W.; Novick, A.C.; Mekhail, T.M.; Olencki, T.E.; Elson, P.; Bukowski, R.M. 2003: F-18 fluorodeoxyglucose positron emission tomography in the evaluation of distant metastases from renal cell carcinoma. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 21(21): 3995-4000
Rao, S.K.; Caride, V.J.; Ponn, R.; Giakovis, E.; Lee, S.H. 2004: F-18 fluorodeoxyglucose positron emission tomography-positive benign adrenal cortical adenoma: imaging features and pathologic correlation. Clinical Nuclear Medicine 29(5): 300-302
Hanif, M.Z.; Ghesani, M.; Shah, A.A.; Kasai, T. 2004: F-18 fluorodeoxyglucose uptake in atherosclerotic plaque in the mediastinum mimicking malignancy: another potential for error. Clinical Nuclear Medicine 29(2): 93-95
Shida, M.; Murakami, M.; Tsukada, H.; Ishiguro, Y.; Kikuchi, K.; Yamashita, E.; Kajiwara, H.; Yasuda, M.; Ide, M. 2007: F-18 fluorodeoxyglucose uptake in leiomyomatous uterus. International Journal of Gynecological Cancer: Official Journal of the International Gynecological Cancer Society 17(1): 285-290
García Velloso, M.J.; Boán García, J.F.; Villar Luque, L.M.; Aramendía Beitia, J.M.; López García, G.; Richter Echeverría, J.A. 2003: F-18-FDG positron emission tomography in the diagnosis of ovarian recurrence. Comparison with CT scan and CA 125. Revista Espanola de Medicina Nuclear 22(4): 217-223
Schmidt, M.; Voth, E.; Schneider, C.A.; Theissen, P.; Wagner, R.; Baer, F.M.; Schicha, H. 2004: F-18-FDG uptake is a reliable predictory of functional recovery of akinetic but viable infarct regions as defined by magnetic resonance imaging before and after revascularization. Magnetic Resonance Imaging 22(2): 229-236
Mikosch, P.; Würtz, F.G.; Gallowitsch, H.-J.ür.; Kresnik, E.; Lind, P. 2003: F-18-FDG-PET in a patient with Hashimoto's thyroiditis and MALT lymphoma recurrence of the thyroid. Wiener Medizinische Wochenschrift 153(3-4): 89-92
Ruiz Franco-Baux, J.V.; Borrego Dorado, I.; Gómez Camarero, P.; Rodríguez Rodríguez, J.R.; Vázquez Albertino, R.J.; Navarro González, E.; Astorga Jiménez, R. 2005: F-18-fluordeoxyglucose positron emission tomography on patients with differentiated thyroid cancer who present elevated human serum thyroglobulin levels and negative I-131 whole body scan. Revista Espanola de Medicina Nuclear 24(1): 5-13
Bleeker-Rovers, C.P.; Bredie, S.J.H.; van der Meer, J.W.M.; Corstens, F.H.M.; Oyen, W.J.G. 2003: F-18-fluorodeoxyglucose positron emission tomography in diagnosis and follow-up of patients with different types of vasculitis. Netherlands Journal of Medicine 61(10): 323-329
Sperti, C.; Pasquali, C.; Decet, G.; Chierichetti, F.; Liessi, G.; Pedrazzoli, S. 2005: F-18-fluorodeoxyglucose positron emission tomography in differentiating malignant from benign pancreatic cysts: a prospective study. Journal of Gastrointestinal Surgery: Official Journal of the Society for Surgery of the Alimentary Tract 9(1): 22-28; Discussion: 28-29
Donckier, V.; Van Laethem, J.L.; Goldman, S.; Van Gansbeke, D.; Feron, P.; Ickx, B.; Wikler, D.; Gelin, M. 2003: F-18] fluorodeoxyglucose positron emission tomography as a tool for early recognition of incomplete tumor destruction after radiofrequency ablation for liver metastases. Journal of Surgical Oncology 84(4): 215-223
Chaise, C.; Itti, E.; Petegnief, Y.; Wirquin, E.; Copie-Bergman, C.; Farcet, J.-P.; Delfau-Larue, M.-H.él.èn.; Meignan, M.; Talbot, J.-N.ël.; Molinier-Frenkel, V.ér. 2007: F-18]-Fluoro-2-deoxy-D: -glucose positron emission tomography as a tool for early detection of immunotherapy response in a murine B cell lymphoma model. Cancer Immunology Immunotherapy: Cii 56(8): 1163-1171
Douglas, J.G.; Stelzer, K.J.; Mankoff, D.A.; Tralins, K.S.; Krohn, K.A.; Muzi, M.; Silbergeld, D.L.; Rostomily, R.C.; Scharnhorst, J.; Spence, A.M. 2006: F-18]-fluorodeoxyglucose positron emission tomography for targeting radiation dose escalation for patients with glioblastoma multiforme: clinical outcomes and patterns of failure. International Journal of Radiation Oncology Biology Physics 64(3): 886-891
Drasgow, J.; Barnette, W.L. 1957: F-K in a motivated group. Journal of Consulting Psychology 21(5): 399-401
Freeman, J.G.; Lucero, R.J. 1956: F-L Fergus Falls lobotomy scale. A.M.A. Archives of Neurology and Psychiatry 76(1): 30-33
Uspenskaya, A.V.; Raikova, O.I. 2004: F-actin and beta-tubulin localization in the myxospore stinging apparatus of Myxobolus pseudodispar Gorbunova, 1936 (Myxozoa, Myxosporea). Tsitologiia 46(8): 748-754
McGregor, E.; Kempster, L.; Wait, R.; Gosling, M.; Dunn, M.J.; Powell, J.T. 2004: F-actin capping (CapZ) and other contractile saphenous vein smooth muscle proteins are altered by hemodynamic stress: a proteonomic approach. Molecular and Cellular Proteomics: Mcp 3(2): 115-124
Pesacreta, T.C.; Carley, W.W.; Webb, W.W.; Parthasarathy, M.V. 1982: F-actin in conifer roots. Proceedings of the National Academy of Sciences of the United States of America 79(9): 2898-2901
Dziewulska-Szwajkowska, D.; Ogorzałek, A. 2005: F-actin, beta-tubulin, aldolase, and fructose-1,6-bisphosphatase in heteropteran ovarioles--I. Immunocytochemical investigations of whole-mounted ovarioles. Cell and Tissue Research 321(2): 311-321
Lange, K.; Gartzke, J. 2006: F-actin-based Ca signaling-a critical comparison with the current concept of Ca signaling. Journal of Cellular Physiology 209(2): 270-287
Jordheim, L.P.; Cros, E.; Galmarini, C.M.; Dumontet, C.; Bretonnet, A-Sophie.; Krimm, I.; Lancelin, J-Marc.; Gagnieu, M-Claude. 2006: F-ara-AMP is a substrate of cytoplasmic 5'-nucleotidase II (cN-II): HPLC and NMR studies of enzymatic dephosphorylation. Nucleosides Nucleotides and Nucleic Acids 25(3): 289-297
Hermand, D. 2006: F-box proteins: more than baits for the SCF?. Cell Division 1: 30
Morse, M. 1973: F-deformations and f-tractions. Proceedings of the National Academy of Sciences of the United States of America 70(6): 1634-1635
Pluim, J.P.W.; Maintz, J.B.A.; Viergever, M.A. 2004: F-information measures in medical image registration. IEEE Transactions on Medical Imaging 23(12): 1508-1516
Xi, H.-W.; Huang, M.-B.; Chen, B.-Z.; Li, W.-Z. 2005: F-loss and H-loss dissociations in low-lying electronic states of the CH3F+ ion studied using multiconfiguration second-order perturbation theory. Journal of Physical Chemistry. a 109(40): 9149-9155
Michalowicz, A.; Provost, K.; Laruelle, S.; Mimouni, A.; Vlaic, G. 1999: F-test in EXAFS fitting of structural models. Journal of Synchrotron Radiation 6(Part 3): 233-235
Kostera-Pruszczyk, A.; Rowińska-Marcińska, K.; Owsiak, S.; Jezierski, P.ł; Emeryk-Szajewska, B. 2004: F-wave amplitude in peripheral nervous system lesions. Neurologia i Neurochirurgia Polska 38(6): 465-470
Trujillo-Hernández, B.ín.; Huerta, M.; Trujillo, X.óc.; Vásquez, C.; Pérez-Vargas, D.; Millán-Guerrero, R.O. 2005: F-wave and H-reflex alterations in recently diagnosed diabetic patients. Journal of Clinical Neuroscience: Official Journal of the Neurosurgical Society of Australasia 12(7): 763-766
Nodera, H.; Kaji, R. 2005: F-wave latency is the most reproducible NCS parameter in repeated studies performed at short intervals. Muscle and Nerve 31(3): 407-408
Fisher, M.A. 2007: F-waves--physiology and clinical uses. Thescientificworldjournal 7: 144-160
Peirce, G.J. 1936: F. A. F. C. Went (1863-1935). Plant physiology 11(2): i4-223
Cooperberg, A.A. 1959: The management of idiopathic thrombocytopenic purpura. Canadian Medical Association Journal 80(12): 937-943
Dubois-Poulsen, A.; Bourdier, F. 1964: F. Bourdier (1877-1963). Archives d'ophtalmologie et revue generale d'ophtalmologie 24: 369-372
Henderson, J.; Gaughran, E.R.L. 1952: Sterility of marker cotton. Journal of the American Medical Association 150(5): 508-509
ten DOESSCHATE, G.; Donders, F.C. 1950: F. C. Donders' last writings. Ophthalmologica. Journal International d'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift für Augenheilkunde 120(6): 434
Reidy, F.Cyril. 1959: F. C. Reidy. British Medical Journal 1(5128): 1048
Naish, F.C. 1959: F. Charlotte Naish. British Medical Journal 1(5127): 977-978
Burnand, R.; Dumarest, F. 1951: F. Dumarest. Revue Medicale de la Suisse Romande 71(10): 686-688
Bariety; Deve, F. 1951: F. Dévé. Revue de Pathologie Comparee 51(633): 51-52
Bazanov, V.A.; Erisman, F.F. 1963: F. F. Erisman and the Department of Hygiene at the Moscow University (Based on new Documents). Gigiena i sanitariia 28: 40-44
Bazanov, V.A.; Erisman, F.F. 1965: F. F. Erisman under the Surveillance of the Tsarist Secret Police. Sovetskoe Zdravookhranenie 24: 43-51
Goeva, O.E. 1960: F. F. Erisman in Petersburg. Sovetskoe Zdravookhranenie 19(2): 64-70
Boyer, P.D.; Bier, M.; Nord, F.F. 1959: F. F. Nord: dedication. Archives of Biochemistry and Biophysics 83(1): 1
Steward, F.C. 1962: F. G. Gregory 1893-1961. Plant Physiology 37(3): 450
Eijkel, R.N.M.; Haase, F.G.M. 1950: F. G. M. Haase fifty years a physician. Nederlands Tijdschrift Voor Geneeskunde 94(21): 1526
Lankovits, A.V.; Pravosud, F.G. 1953: F. G. Pravosud and his obstetrical forceps. Akusherstvo i Ginekologiia 2: 75-78
Williams, F.G.H. 1960: F. Garfield Hodder WILLIAMS. British Medical Journal 2(5198): 608-609
Marble, A.; Brigham, F.GORHAM. 1964: F. Gorham Brigham 1882-1964. Diabetes 13: 435
Shortt, W.H.; Hope-Jones, F. 1950: F. Hope-Jones. Nature 165(4203): 792-793
Shakhbazian, E.S.; Inozemtsev, F. 1951: F. I. Inozemtsev (1802-1869). Sovetskaia meditsina 1: 35-38
Molchanov, N.S.; Pasternatskii, F.I. 1954: F. I. Patsernatskii (scientific, medico-pedagogical and social activity). Klinicheskaia Meditsina 32(11): 75-80
Kleine, F.KARL. 1951: F. K. Kleine, M.D. British medical journal 1(4712): 954-955
Boucek, B.; Studnicka, F.K. 1950: F. K. Studni6cka, student biology. Casopis Lekaru Ceskych 89(47): 1333-1336
Mignani, E.; Del Vivo, R.E. 1955: F. Klinge's allergic arthritis in immobility and movement. Archivio "de Vecchi" Per l'Anatomia Patologica E la Medicina Clinica 23(2): 687-710
Pietrantoni, L. 1950: F. Lasagna audiological department of the Otorhinolaryngology Clinic of the University of Milan. Archivio Italiano di Otologia Rinologia e Laringologia 61(Suppl. 5): 1-7
Riel, G. 2006: F. M. Cummings--"A useful formula for the calibration laboratory". Health Physics 91(6): 646
Lossen, H.; Groedel, F.M. 1951: F. M. Groedel as roentgenologist. Experimental Medicine and Surgery 9(2-4): 213-219
Kremen, A.J. 1952: History of blood transfusion. Journal-Lancet 72(7): 319-324
Broadus, R.N. 1963: F. Matthias Alexander as a speech clinician: an historical note. Journal of Speech and Hearing Disorders 28: 91-94
Taylor, F.O. 1952: F. O. Taylor. Texas State Journal of Medicine 48(6): 412
Stochik, A.M.; Iarovinskiĭ, M.Ia.; Gaaz, F.Iosifovich. 2004: F. P. Gaaz and the problems of medical ethics. Klinicheskaia Meditsina 82(7): 72-74
Von Kreudenstein, T.S.; Proell, F. 1953: F. Proell's optical polarization tests. Deutsche Zahnarztliche Zeitschrift 8(11): 635-637
Eddison, F.R. 1959: F. R. Eddison. British Medical Journal 1(5135): 1479-1480
Pagel, W.; Bodenheimer, F.S. 1960: F. S. Bodenheimer (1897-1959). Journal of the History of Medicine and Allied Sciences 15: 96-97
Sister Mary Sylvia 1959: F. S. Q. Hospital Progress 40(3): 93
Toy, F.C.; Pierce, F.T. 1950: F. T. Peirce. Nature 165(4204): 835-836
Gruzdev, V.F.; Karzhavin, F.V. 1960: F. V. KARZHAVIN, "Russian Doctor". Sovetskoe Zdravookhranenie 19(8): 75-76
Marchionini, A.; Schelling, F.W. 1955: F. W. Schelling and the physicians of his time. Munchener Medizinische Wochenschrift 97(2): 52-54
Savory, J.; Sunderman, F.William. 2003: F. William Sunderman MD, PhD (1898-2003). Clinical chemistry 49(7): 1235-1237
Li, C.; Ren, S.-F.; Hou, J.-L.; Yi, H.-P.; Zhu, S.-Z.; Jiang, X.-K.; Li, Z.-T. 2005: F...H-N hydrogen bonding driven foldamers: efficient receptors for dialkylammonium ions. Angewandte Chemie 44(35): 5725-5729
White, F.A. 1952: F.A. White. Texas State Journal of Medicine 48(11): 790
Eve, F.CECIL. 1952: F.C. Eve, M.D., F.R.C.P. British medical journal 2(4798): 1362
Hoyte, F.C. 1958: F.C. Hoyte. British Medical Journal 2(5091): 332
Saul, S. 2005: F.D.A. approves a heart drug for African-Americans. New York Times on the Web 2005: C2
Harris, G. 2006: F.D.A. approves broader access to next-day pill; sales over the counter; change just for adults--contraceptive still tied to abortion battle. New York Times on the Web 2006: A1 A18
Pollack, A. 2003: F.D.A. asks if a genetic test is sold without approval. New York Times on the Web 2003: C2
Harris, G. 2006: F.D.A. dismisses medical benefit from marijuana. New York Times on the Web 2006: A1 A23
Meier, B. 2005: F.D.A. had report of short circuit in heart devices; confidentiality at issue; policies of regulator may keep data on problems away from doctors. New York Times on the Web 2005: A1 A18
Saul, S. 2005: F.D.A. panel approves heart remedy for blacks. New York Times on the Web 2005: C4
Deichmann, W.B. 1963: F.D.A. requirements for food additives in the U.S.A. Archiv für Toxikologie 20: 1-11
Saul, S. 2006: F.D.A. shifts view on next-day pill; moves toward backing its sale over the counter. New York Times on the Web 2006: A1 A12
Pollack, A.; Martin, A. 2006: F.D.A. tentatively declares food from clones animals to be safe; critics say risks have not been fully weighed. New York Times on the Web 2006: A1 A23
Harris, G. 2005: F.D.A. to weigh at-home testing for AIDS virus. New York Times on the Web 2005: A1 A16
Zernike, K. 2006: F.D.A.'s report illuminates wide divide on marijuana. New York Times on the Web 2006: A11
Camalier, C.W. 1958: F.D.I. representative suggests extension of dental program for WHO. Journal of the American Dental Association 56(6): 858
Higgins, T.T.; Batten, F.E. 1961: F.E. Batten, 1865-1918. Cerebral palsy bulletin 3: 527-528
Jardine, F.E. 1956: F.E. Jardine. British Medical Journal 1(4970): 807-808
Willis, F.EDWARD.SAXBY. 1953: F.E. Saxby Willis. British Medical Journal 1(4803): 222
Magazanik, M.L.; Ianovskii, F.GAVRILOVICH. 1952: F.G. Ianovskii as phthisiologist. Problemy Tuberkuleza 6: 50-56
Glazebrook, A.J. 1952: Actions and uses of methorphinan. British Medical Journal 2(4798): 1328-1330
Rossiiskii, D.M.; Inozemtsev, F.L. 1954: F.I. Inozemtsev as a chemotherapeutist and his significance in the development of Russian chemotherapy. Farmakologiia i Toksikologiia 17(5): 56-59
Anonymous 1952: F.I.D. congress, London, 1952. Tijdschrift Voor Tandheelkunde 59(11): 836-862
Browne, F.JAMES. 1963: F.J. Browne. Journal of Obstetrics and Gynaecology of the British Commonwealth 70: 1081-1082
Livianos-Aldana, L.; Rojo-Moreno, L.; Sierra-Sanmiguel, P.; Gall, F. 2007: F.J. Gall and the phrenological movement. American Journal of Psychiatry 164(3): 414
Barrington, F.J. 1956: F.J.F. Barrington. British Medical Journal 1(4970): 808
Schulte, D.; Walach, H. 2006: F.M. Alexander technique in the treatment of stuttering-- a randomized single-case intervention study with ambulatory monitoring. PsychoTherapy and Psychosomatics 75(3): 190-191
Flabeau, F.; Cadenat, F.M. 1965: F.M. Cadenat (1883-1964). La Presse medicale 73: 375-376
Dreyfuss, F.; Librach, G. 1952: Cold precipitable serum globulins (cold fractions, cryoglovulins) in subacute bacterial endocarditis. Journal of Laboratory and Clinical Medicine 40(4): 489-497
Giraud, J.C.; Sudaka, J. 1958: Study of diphtheric esophageal stenosis. Algerie Medicale 62(4): 429-432
Reynolds, F.NEON. 1953: F.N. Reynolds, F.R.C.S. Ed., F.R.C.O.G. British Medical Journal 1(4800): 46-47
Potter, V.R. 1951: Studies on the reactions of the Krebs citric acid cycle in tumor, with homogenates, slices, and in vivo technics. Cancer Research 11(8): 565-570
Jackson, R.J. 1964: F.O.C.L.A.'s first Ten Years of Medical Teaching. Medical journal of Australia 1: 51-52
Poulain, S.; Dargent, M.; Mayer, M.; Pommatau, E. 1964: F.S.H. in Metastatic Cancer of the Breast in Women. Acta - Unio Internationalis Contra Cancrum 20: 1486-1488
Edridge-Green, F.WILLIAM. 1953: F.W. Edridge-Green. British Medical Journal 1(4817): 998
Price, F.W. 1957: F.W. Price. British Medical Journal 1(5021): 765
Dimitrov, A.; Heidemann, D.; Kemnitz, E. 2006: F/Cl-exchange on AlCl(3)-pyridine adducts: synthesis and characterization of trans-difluoro-tetrakis-pyridine-aluminum-chloride, [AlF2(Py)4]+Cl-. Inorganic Chemistry 45(26): 10807-10814
Myers, S. 2003: F0 timing in Kinyarwanda. Phonetica 60(2): 71-97
Walldorf, U.; Hovemann, B.; Bautz, E.K. 1985: F1 and F2: two similar genes regulated differently during development of Drosophila melanogaster. Proceedings of the National Academy of Sciences of the United States of America 82(17): 5795-5799
Zinder, N.D.; Valentine, R.C.; Roger, M.; Stoeckenius, W. 1963: F1, a Rod-Shaped Male-Specific Bacteriophage that Contains DNA. Virology 20: 638-640
Meka-Mechenko, T.V. 2003: F1-negative natural Y. pestis strains. Advances in Experimental Medicine and Biology 529: 379-381
Zor, E.; Stokkel, M.P.; Ozalp, S.; Vardareli, E.; Yalçin, O.Tarik.; Ak, I. 2006: F18-FDG coincidence-PET in patients with suspected gynecological malignancy. Acta Radiologica 47(6): 612-617
van der Laan, M.; Bechtluft, P.; Kol, S.; Nouwen, N.; Driessen, A.J.M. 2004: F1F0 ATP synthase subunit c is a substrate of the novel YidC pathway for membrane protein biogenesis. Journal of Cell Biology 165(2): 213-222
Gavin, P.D.; Prescott, M.; Devenish, R.J. 2005: F1F0-ATP synthase complex interactions in vivo can occur in the absence of the dimer specific subunit e. Journal of Bioenergetics and Biomembranes 37(2): 55-66
Feldkamp, T.; Kribben, A.; Weinberg, J.M. 2005: F1FO-ATPase activity and ATP dependence of mitochondrial energization in proximal tubules after hypoxia/reoxygenation. Journal of the American Society of Nephrology: Jasn 16(6): 1742-1751
Gibson, T.; Ohde, R.N. 2007: F2 locus equations: phonetic descriptors of coarticulation in 17- to 22-month-old children. Journal of Speech Language and Hearing Research: Jslhr 50(1): 97-108
Salahudeen, A.K.; Reckelhoff, J.F.; Morrow, J.D.; Roberts, L.J. 1998: F2-isoprostanes and the kidney. Drug News and Perspectives 11(5): 287-290
Wiswedel, I.; Hirsch, D.; Carluccio, F.; Hampl, H.; Siems, W. 2005: F2-isoprostanes as biomarkers of lipid peroxidation in patients with chronic renal failure. Biofactors 24(1-4): 201-208
Montine, T.J.; Montine, K.S.; McMahan, W.; Markesbery, W.R.; Quinn, J.F.; Morrow, J.D. 2005: F2-isoprostanes in Alzheimer and other neurodegenerative diseases. Antioxidants and Redox Signaling 7(1-2): 269-275
Gutierrez, G. 2005: F2-isoprostanes: potential markers of oxidative stress during resuscitation. Critical Care Medicine 33(9): 2137-2138
Bader, M.A.; Kappel, C.; Selle, A.é; Ihlemann, J.ür.; Ng, M.L.; Herman, P.R. 2006: F2-laser-machined submicrometer gratings in thin dielectric films for resonant grating waveguide applications. Applied Optics 45(25): 6586-6590
Basnuevo, J.G.; Figares, E. 1957: F2AM solution and rectal mucous scraping in the diagnosis of amebiasis. Revista Kuba de Medicina Tropical y Parasitologia 13(7-12): 60-66
Basnuevo, J.G.; Figares, E. 1957: F2AM solution for the conservation of trophozoites and cysts of Endamoeba histolytica. Revista Kuba de Medicina Tropical y Parasitologia 13(7-12): 85-87
Basnuevo, J.G.; Figares, E. 1958: F2AM solution for the preservation of trophozoites and cysts of Endamoeba histolytica. ARCHIVOS. Hospital Universitario General Calixto Garcia 10(3): 220-221
Hammerl, A.; Welch, B.J.; Schwerdtfeger, P. 2004: F2Al(mu-eta2:eta2-O2)AlF2: an unusual, stable aluminum peroxo compound. Inorganic Chemistry 43(4): 1436-1440
Huber, J.T.; Dietrich, J.D.; Cugini, E.; Burke, S. 2005: F2F connection: a community health information needs assessment of Texas families who have children with chronic illnesses and/or disabilities and their care providers. Journal of the Medical Library Association: Jmla 93(2): 278-281
Levänen, V.; Lauerma, H. 2003: F99, a mental disorder not otherwise specified. Duodecim; Laaketieteellinen Aikakauskirja 119(4): 343; 345
Weng, D. 2004: FAAS determination of trace elements in tea-leaves using suspension sampling with ultrasonic agitation. Guang Pu Xue Yu Guang Pu Fen Xi 24(11): 1458-1460
Kuriyama, K. 2003: FAB amd WHO classification of leukemia. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 92(6): 934-941
Sharma, J.S.; Mohindroo, S. 2004: FAB classification of leukemia: a cytochemical study. Indian Journal of Pathology and Microbiology 47(3): 336-339
Rodriguez del Alamo, A.; Catalán Alonso, M.J.; Carrasco Marín, L. 2003: FAB: a preliminar Spanish application of the frontal assessment battery to 11 groups of patients. Revista de Neurologia 36(7): 605-608
Jordal, A.-E.O.; Hordvik, I.; Pelsers, M.; Bernlohr, D.A.; Torstensen, B.E. 2006: FABP3 and FABP10 in Atlantic salmon (Salmo salar L.)--general effects of dietary fatty acid composition and life cycle variations. Comparative Biochemistry and Physiology. Part B Biochemistry and Molecular Biology 145(2): 147-158
Juengst, E.T. 2004: FACE facts: why human genetics will always provoke bioethics. Journal of Law Medicine and Ethics: a Journal of the American Society of Law Medicine and Ethics 32(2): 267-275; 191
Ardran, G.M.; Kemp, F.H. 1951: The mechanism of swallowing. Proceedings of the Royal Society of Medicine 44(12): 1038-1040
Stocks, P. 1953: A study of the age curve for cancer of the stomach in connection with a theory of the cancer producing mechanism. British Journal of Cancer 7(4): 407-417
Anonymous 1953: FACILITIES increase for rural medical care. Minnesota Medicine 36(4): 395-396
Humphrey, J.H. 1952: The homeroom as a medium for health guidance. Journal of School Health 22(9): 264-268
Anonymous 1953: FACILITY for use of radioactive isotopes in a general hospital. Public Health Reports 68(4): 449-450
Anonymous 1952: FACING disability. Lancet 2(6734): 572
Li, A.; Kaur, P. 2005: FACS enrichment of human keratinocyte stem cells. Methods in Molecular Biology 289: 87-96
Herzenberg, L.A. 2004: FACS innovation: a view from Stanford. Clinical and Investigative Medicine. Medecine Clinique et Experimentale 27(5): 240-252
Schmidt, M.; Hourfar, M.K.; Nicol, S.-B.; Spengler, H.-P.; Montag, T.; Seifried, E. 2006: FACS technology used in a new rapid bacterial detection method. Transfusion Medicine 16(5): 355-361
Taylor, W.R. 2004: FACS-based detection of phosphorylated histone H3 for the quantitation of mitotic cells. Methods in Molecular Biology 281: 293-299
Castle, W.E. 1951: Dominant and recessive black in mammals. Journal of Heredity 42(1): 48-49
Griffin, A.C.; Dolman, V.S.; Bohlke, E.B.; Bouvart, P.; Tatum, E.L. 1955: The effect of visible light on the carcinogenicity of ultraviolet light. Cancer Research 15(8): 523-528
Scholler, J.; Philips, F.S.; Bittner, J.J. 1955: Assays with first- or second-generation transplants of spontaneous mammary adenocarcinomas of mice. Cancer Research Suppl. 3(2): 32-37
Anonymous 1952: FACT and theory in influenza research. Lancet 2(6724): 74
Distefano, G. 1953: Experimental research on resistance of the thyroid gland to tuberculous infection and reinfection. Minerva Chirurgica 8(10): 447-452
Anonymous 2005: FACT study: benefits of alendronate. MMW Fortschritte der Medizin 147(1-2): 52-53
Kokocinski, F.; Delhomme, N.; Wrobel, G.; Hummerich, L.; Toedt, G.; Lichter, P. 2005: FACT--a framework for the functional interpretation of high-throughput experiments. Bmc Bioinformatics 6: 161
Thomas, B.C.; Pandey, M.; Ramdas, K.; Sebastian, P.; Nair, M.K. 2004: FACT-G: reliability and validity of the Malayalam translation. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment Care and Rehabilitation 13(1): 263-269
Dujardin, J.J.; Steg, P.G.; Puel, J.; Montalescot, G.; Ravaud, P.; Goldstein, P.; Jullien, G.; Chevalier, B.; Monassier, J.P.; Huynh-Ba, O.; Kempf, C. 2003: FACT: French national registry of acute coronary syndromes. Specific study of French general hospital centers. Annales de Cardiologie et d'Angeiologie 52(5): 337-343
Isaacs, M.L. 1930: Factors which Influence tests of Bacterial Survival Ii. the effect of the Ph of the Survival test Culture on Results Obtained with a Saprophytic Tubercle Bacillus. Journal of Bacteriology 20(3): 175-181
Anonymous 1958: FACTORS affecting iron absorption. Nutrition Reviews 16(4): 113-114
Anonymous 1960: FACTORS controlling cholesterol excretion. Nutrition Reviews 18: 19-21
Anonymous 1957: FACTORS in perinatal mortality. Journal. Iowa State Medical Society 47(7): 396-397
Anonymous 1954: FACTORS in the success of students in schools of practical nursing. Nursing Outlook 2(8): 423-427
Anonymous 1954: FACTORS influencing carotene and protein contents of alfalfa. Nutrition Reviews 12(5): 137-138
Anonymous 1953: FACTORS influencing the level of free choline in plasma. Nutrition Reviews 11(10): 309-311
Anonymous 1950: FACTORS influencing the occurrence of neonatal tetany. Nutrition Reviews 8(10): 296-298
Anonymous 1951: FACTORS influencing vitamin A storage in rats. Nutrition Reviews 9(10): 300-302
Anonymous 1951: FACTORS that influence the nutritive value of legume seeds. Nutrition Reviews 9(1): 28-30
Anonymous 1952: FACTS about BCG. Lancet 1(6715): 953-954
Anonymous 1953: FACTS about Blue Shield of Wisconsin; an agency of the State Medical Society of Wisconsin. Wisconsin Medical Journal 52(2): 158
Anonymous 1953: FACTS about nursing. Lancet 1(6756): 379-380
Parker, R.T.; Cuyler, W.K.; Kaufmann, L.A.; Peete, C.H.; Carter, B. 1957: Present concepts in the diagnosis and management of intraepithelial (stage O) carcinoma of the cervix uteri. North Carolina Medical Journal 18(7): 261-268
Nikol'skaia, B.S. 1954: Investigations on styptic and wound healing properties from vegetable origin. TRUDY. Vsesoiuznoe Fiziologicheskoe Obshchestvo Imeni I. P. Pavlova. Orenburgskoe Otdelenie 2(3): 194-197
Anonymous 1958: FACTS and figures about Dutch women in medicine. Journal of the American Medical Women's Association 13(6): 251-253
Anonymous 1953: FACTS from general practice. Lancet 265(6793): 978-979
Benchimol, N.B. 1952: Menstrual disorders; diagnosis and treatment. Brasil-Medico 66(31-32): 477-488
Shioi, J.; Georgakopoulos, A.; Mehta, P.; Kouchi, Z.; Litterst, C.M.; Baki, L.; Robakis, N.K. 2007: FAD mutants unable to increase neurotoxic Abeta 42 suggest that mutation effects on neurodegeneration may be independent of effects on Abeta. Journal of Neurochemistry 101(3): 674-681
Papp, E.; Nardai, G.áb.; Mandl, J.óz.; Bánhegyi, G.áb.; Csermely, P.ét. 2005: FAD oxidizes the ERO1-Pdi electron transfer chain: the role of membrane integrity. Biochemical and Biophysical Research Communications 338(2): 938-945
Anusevicius, Z.; Miseviciene, L.; Medina, M.; Martinez-Julvez, M.; Gomez-Moreno, C.; Cenas, N. 2005: FAD semiquinone stability regulates single- and two-electron reduction of quinones by Anabaena PCC7119 ferredoxin:NADP+ reductase and its Glu301Ala mutant. Archives of Biochemistry and Biophysics 437(2): 144-150
Tourneur, L.éa.; Buzyn, A.ès.; Chiocchia, G. 2005: FADD adaptor in cancer. Medical Immunology 4(1): 1
Hu, P.; Wang, G.; Zhu, X.; Yang, J.; Zhu, H.; Xu, Z.; Liao, W.; Liu, X.; Xu, F.; Yin, J.; Shen, G.X. 2004: FADDdel-GFP modified mouse insulinoma cells counteract the cytotoxicity of reactive T cells. Cellular and Molecular Immunology 1(5): 383-386
Anonymous 1955: FAECAL incontinence. Medical World 82(6): 581-582
Galloro, V. 2003: FAH rebounds after PR cuts. Modern Healthcare 33(25): 20
Schäfer, U.; Micke, O.; Müller, S.B.; Schüller, P.; Willich, N. 2003: Hemoglobin as an independent prognostic factor in the radiotherapy of head and neck tumors. Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 179(8): 527-534
Towers, G.H.N. 2003: FAHF-1 purporting to block peanut-induced anaphylaxis. Journal of Allergy and Clinical Immunology 111(5): 1140; Author Reply 1140-1
Rey Ardid, R. 1956: Cerebral metabolism and biochemical alterations in endogenous psychoses. Revista Clinica Espanola 60(5): 281-286
Anonymous 1957: FAILURE of arterial grafts. Lancet 272(6961): 203-204
Anonymous 1953: FAILURE of diuresis in cardiac failure. Medical Journal of Australia 1(14): 485
Anonymous 1955: FAILURE to attend patient on trolley. British Medical Journal 2(4930): 65
Shvartsburg, A.A.; Tang, K.; Smith, R.D. 2005: FAIMS operation for realistic gas flow profile and asymmetric waveforms including electronic noise and ripple. Journal of the American Society for Mass Spectrometry 16(9): 1447-1455
Anonymous 1953: FAIR trial and no favour. Medical World 78(4): 389-391
Castro-Pareja, C.R.; Jagadeesh, J.M.; Shekhar, R. 2003: FAIR: a hardware architecture for real-time 3-D image registration. IEEE Transactions on Information Technology in Biomedicine: a Publication of the IEEE Engineering in Medicine and Biology Society 7(4): 426-434
Anonymous 1950: FAIRCHILD-Huxley chest respirator accepted. Journal of the American Medical Association 143(13): 1157
Giresi, P.G.; Kim, J.; McDaniell, R.M.; Iyer, V.R.; Lieb, J.D. 2007: FAIRE (Formaldehyde-Assisted Isolation of Regulatory Elements) isolates active regulatory elements from human chromatin. Genome Research 17(6): 877-885
Nagano, H.; Monden, M. 2006: FAIT (FU arterial infusion and interferon therapy) for hepatocellular carcinoma. Nihon Rinsho. Japanese Journal of Clinical Medicine 64(7): 1314-1318
Weis, W.D. 1952: FAITHFUL public servant. Journal of the Indiana State Medical Association 45(11): 1166
Yin, H.; Wang, L.-h.; Huo, Y.; Peng, X.; Xia, C.-f.; Tang, C.-s. 2002: FAK antisense oligodeoxynucleotides inhibit vascular smooth muscle cell migration and adhesion mediated by FAK-ERK1/2 signaling pathway. Yao Xue Xue Bao 37(5): 334-338
Chang, F.; Lemmon, C.A.; Park, D.; Romer, L.H. 2007: FAK potentiates Rac1 activation and localization to matrix adhesion sites: a role for betaPIX. Molecular Biology of the Cell 18(1): 253-264
Qin, J.; Liu, Z.-X. 2006: FAK related non-kinase (FRNK) inhibits migration of a human breast carcinoma cell line MDA-MB-435. Ai Zheng 25(7): 833-838
Natarajan, M.; Hecker, T.P.; Gladson, C.L. 2003: FAK signaling in anaplastic astrocytoma and glioblastoma tumors. Cancer Journal 9(2): 126-133
Mon, N.N.; Ito, S.; Senga, T.; Hamaguchi, M. 2006: FAK signaling in neoplastic disorders: a linkage between inflammation and cancer. Annals of the new York Academy of Sciences 1086: 199-212
Hamilton, T.S. 1957: The foreign trained physician; a joint approach to a multifaceted problem. Hospitals 31(15 Part 1): 32
Gengozian, N.; Makinodan, T. 1957: Mortality of mice as affected by variation of the x-ray dose and number of nucleated rat bone marrow cells injected. Cancer Research 17(10): 970-975
Anonymous 1958: FALLOPIAN tube carcinoma. Cancer Bulletin 10(1): 13
Wagner, K.; Stepantschitz, G.; Stepan, K.M.; Voill, F. 1955: Course of experimental hemolytic anemia in splenectomized or trypan blue pre-treated rats. Folia Haematologica 73(2): 231-235
Khare, S.D.; Caplow, M.; Dokholyan, N.V. 2006: FALS mutations in Cu, Zn superoxide dismutase destabilize the dimer and increase dimer dissociation propensity: a large-scale thermodynamic analysis. Amyloid: the International Journal of Experimental and Clinical Investigation: the Official Journal of the International Society of Amyloidosis 13(4): 226-235
Melick, W.F.; Boler, T.D.; Black, H. 1953: Translumbar aortography in infants utilizing 70 per cent urokon as a contrast medium. Missouri Medicine 50(3): 179-182
Yao, Z.; Xiao, J.; Tung, A.K.H.; Sung, W.K. 2005: FAMCS: finding all maximal common substructures in proteins. Genomics Proteomics and Bioinformatics 3(2): 107-119
Stegmann, M.B.; Ersbøll, B.K.; Larsen, R. 2003: FAME--a flexible appearance modeling environment. IEEE Transactions on Medical Imaging 22(10): 1319-1331
Swinehart, J.M. 2004: FAMI: is fat really injected into the muscle?. Dermatologic surgery: official publication for American Society for Dermatologic Surgery 30(4 Pt 1): 579; author reply 579-80
Anonymous 1953: FAMILIAL chronic lymphatic leuchaemia. Medical Journal of Australia 1(12): 415
Anonymous 1960: FAMILIAL disturbances of bilirubin metabolism. British Medical Journal 1(5185): 1553-1554
Anonymous 1959: FAMILIAL hemophagocytic reticulosis. Revista Clinica Espanola 74: 46-47
Mixson, W.T.; Woloshin, H.J. 1956: Hiatus hernia in pregnancy. Obstetrics and Gynecology 8(3): 249-260
Anonymous 1952: FAMILIAL hypoplastic anaemia and congenital defects. Lancet 2(6739): 819
Anonymous 1960: FAMILIAL intestinal polypois. British Medical Journal 1(5186): 1627-1628
Anonymous 1959: FAMILIAL juvenile nephronophthisis (Fanconi). Actualidad Pediatrica; Revista de Bibliografia Internacional 16: 101-106
Blehova, B.; Opplt, J. 1958: Metabolic changes in gargoylism. Casopis Lekaru Ceskych 97(31-32): 987-1000
Schumacher, K.; Beck, C.A.; Marren, J.M. 2006: FAMILY CAREGIVERS: caring for older adults, working with their families. American Journal of Nursing 106(8): 40-49; Quiz 50
Anonymous 1953: FAMILY dental survey. I. Dental health concepts. Journal of the American Dental Association 47(5): 578-580
Von STAPELMOHR, R. 1951: Physician, clergyman, patient; considerations on patient and hospital care. Social-Medicinsk Tidskrift 28(7-8): 129-133
Parkinson, T. 1953: Pleural, pericardial, and peritoneal tap. British Medical Journal 2(4843): 985-986
Anonymous 1952: FAMILY history: a record in general practice?. Medical World 77(12): 326-330
Mascall, N. 1958: Diagnosis of the venereal diseases. Medical World 88(5): 409-415
Anonymous 1952: FAMILY life in Great Britain. Lancet 2(6742): 991
Murless, B.C. 1951: Conservation of the ovary in pelvic surgery. South African Medical Journal 25(47): 853-855
Anonymous 1951: FAMILY prognosis in epilepsy. British Medical Journal 2(4743): 1330
Anonymous 1953: FAMILY size and intelligence. Lancet 265(6781): 333
Ellis, F.P. 1952: Hot-climate fatigue in the Royal Navy; a review of lay opinion. Lancet 2(6733): 527-531
Rankin, S.H.; Butzlaff, A.; Carroll, D.L.; Reedy, I. 2005: FAMISHED for support: recovering elders after cardiac events. Clinical Nurse Specialist Cns 19(3): 142-149
Czajkowski, R.ł; Placek, W.; Drewa, G.; Czajkowska, A.; Uchańska, G. 2004: FAMMM syndrome: pathogenesis and management. Dermatologic Surgery: Official Publication for American Society for Dermatologic Surgery 30(2 Part 2): 291-296
Beaumont, W. 1952: FAMOUS Beaumont painting presented to MSMS by Wyeth, Inc. Journal - Michigan State Medical Society 51(11): 1394-1396
Cairns, H.WILLIAM. 1952: FAMOUS brain surgeon dead: Sir Hugh William Cairns. Indian Medical Journal 46(8): Suppl. 47
Anonymous 1953: FAMOUS ophthalmologists of Jewish origin, 1850-1900. Eye Ear Nose and Throat Monthly 32(7): 393-400; Passim
Takeda-Shitaka, M.; Terashi, G.; Chiba, C.; Takaya, D.; Umeyama, H. 2006: FAMS complex: a fully automated homology modeling system for protein complex structures. Medicinal Chemistry 2(2): 191-201
Chen, F.; Peng, G.-J.; Zhang, K.; Hu, Q.; Zhang, L.-Q.; Liu, A.-G. 2005: FANCA gene mutation analysis in Fanconi anemia patients. Zhonghua Xue Ye Xue Za Zhi 26(10): 616-618
Ferrer, M.; Span, S.W.; Vischioni, B.; Oudejans, J.J.; van Diest, P.J.; de Winter, J.P.; Giaccone, G.; Kruyt, F.A.E. 2005: FANCD2 expression in advanced non-small-cell lung cancer and response to platinum-based chemotherapy. Clinical Lung Cancer 6(4): 250-254
Meetei, A.R.; Yan, Z.; Wang, W. 2004: FANCL replaces BRCA1 as the likely ubiquitin ligase responsible for FANCD2 monoubiquitination. Cell Cycle 3(2): 179-181
Bono, H.; Kasukawa, T.; Furuno, M.; Hayashizaki, Y.; Okazaki, Y. 2003: FANTOM-DB: database of functional annotation of RIKEN mouse cDNA clones. Seikagaku. Journal of Japanese Biochemical Society 75(2): 149-152
Jutzi, S.C. 2006: FAO address. Developments in Biologicals 124: 5-9
Anonymous 2006: FAO addresses antimicrobials in aquaculture. Journal of the American Veterinary Medical Association 228(11): 1655
Aykroyd, W.R. 1956: FAO and nutrition. Proceedings of the Nutrition Society 15(1): 4-13
Margetts, B. 2003: FAO/WHO launch expert report on diet, nutrition and prevention of chronic diseases. Public Health Nutrition 6(4): 323-325
Kameyama, K.; Takami, H. 2001: FAP associated thyroid carcinoma in mother and her daughter. Familial Cancer 1(2): 83-86
Camp, E.R.; Hochwald, S.N.; Liu, C. 2004: FAP with concurrent duodenal adenomatous polyposis and carcinoid tumor. Journal of Surgical Oncology 87(4): 187-190
Wieckowski, E.; Atarashi, Y.; Stanson, J.; Sato, T.-A.; Whiteside, T.L. 2007: FAP-1-mediated activation of NF-kappaB induces resistance of head and neck cancer to Fas-induced apoptosis. Journal of Cellular Biochemistry 100(1): 16-28
Wise, R. 2004: FAQs about automated external defibrillators. Michigan Medicine 103(3): 22-23
Perry, J.; Jagger, J. 2005: FAQs about implementing safety devices. Nursing 35(10): 74-76
Mansour, D. 2005: FAQs in hormone replacement therapy. Practitioner 249(1676): 778-782
Atiushev, G.P.; Motvkina, N.S. 2003: Anti-inflammatory, antimicrobial and antidesquamative effect of "Uro-Biofon" in treating sexually transmitted urogenital infections. Urologiia 47(2): 26-28
Lennard, T.W.J.; Harvey, J.R. 2004: FAQs: breast pain and fibroadenosis. Practitioner 248(1663): 686; 688-691 Passim
McLaughlin, J. 2004: FAQs: gastrointestinal motility disorders. Practitioner 248(1658): 320; 323-328
Whorwell, P. 2006: FAQs: irritable bowel syndrome. Practitioner 250(1689): 29-30; 32
Belal, M.; Abrams, P. 2004: FAQs: lower urinary tract symptoms in men. Practitioner 248(1662): 652; 654 656 Passim
Fisher, C.A.H.; Larner, A.J. 2006: FAQs: memory loss. Practitioner 250(1683): 14-16; 19, 21
Slater, D.H. 2006: FAQs: neurological illness and driving. Practitioner 250(1685): 4-6; 8 10-11
Chang, J.; Macartney, H.H.; Graves, H.B. 1957: Clinical experience with fluothane, a new non-explosive anaesthetic agent. Canadian Anaesthetists' Society Journal 4(3): 187-206
Nolen, R.S. 2002: FARAD gets new life in 2002. Journal of the American Veterinary Medical Association 220(1): 6-7
Anonymous 1958: FARGO Tornado; medical aspects. Journal-Lancet 78(7): 307-310
Anonymous 1952: FARM Bureau on record in favor of community health councils. West Virginia Medical Journal 48(10): 309
Anonymous 1953: FARM accidents. Journal of the American Medical Association 153(1): 34-35
Foehr, E.D.; Lorente, G.; Vincent, V.; Nikolich, K.; Urfer, R. 2005: FAS associated phosphatase (FAP-1) blocks apoptosis of astrocytomas through dephosphorylation of FAS. Journal of Neuro-Oncology 74(3): 241-248
Takahashi, H.; Feuerhake, F.; Kutok, J.L.; Monti, S.; Dal Cin, P.; Neuberg, D.; Aster, J.C.; Shipp, M.A. 2006: FAS death domain deletions and cellular FADD-like interleukin 1beta converting enzyme inhibitory protein (long) overexpression: alternative mechanisms for deregulating the extrinsic apoptotic pathway in diffuse large B-cell lymphoma subtypes. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 12(11 Part 1): 3265-3271
Elliott, E.J.; Bower, C. 2004: FAS in Australia: fact or fiction?. Journal of Paediatrics and Child Health 40(1-2): 8-10
McIlroy, D.; Théodorou, I.; Ratziu, V.; Vidaud, D.; Pellet, P.; Debré, P.; Poynard, T. 2005: FAS promoter polymorphisms correlate with activity grade in hepatitis C patients. European Journal of Gastroenterology and Hepatology 17(10): 1081-1088
Nadal, C.; Maurel, J.; Gallego, R.; Castells, A.; Longarón, R.; Marmol, M.; Sanz, S.; Molina, R.; Martin-Richard, M.; Gascón, P. 2005: FAS/FAS ligand ratio: a marker of oxaliplatin-based intrinsic and acquired resistance in advanced colorectal cancer. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 11(13): 4770-4774
Warby, S.; MacDonald, M.; Hayden, M.; Butland, S.; Ouellette, F. 2006: FASA-57 cDNA shares no homology with coding sequence of HD gene. Journal of Reproductive Immunology 69(1): 9
Kalberg, W.O.; Buckley, D. 2007: FASD: what types of intervention and rehabilitation are useful?. Neuroscience and Biobehavioral Reviews 31(2): 278-285
Anonymous 2006: FASEB opposes using science classes to teach intelligent design, creationism, and other non-scientific beliefs. Faseb Journal: Official Publication of the Federation of American Societies for Experimental Biology 20(3): 408-409
Sun, T.; Zhou, Y.; Li, H.; Han, X.; Shi, Y.; Wang, L.; Miao, X.; Tan, W.; Zhao, D.; Zhang, X.; Guo, Y.; Lin, D. 2005: FASL -844C polymorphism is associated with increased activation-induced T cell death and risk of cervical cancer. Journal of Experimental Medicine 202(7): 967-974
Holm, L.-E. 2004: FASSET and implications for work within the ICRP. Journal of Radiological Protection: Official Journal of the Society for Radiological Protection 24(4a): 2 P
Tayal, V.S.; Beatty, M.A.; Marx, J.A.; Tomaszewski, C.A.; Thomason, M.H. 2004: FAST (focused assessment with sonography in trauma) accurate for cardiac and intraperitoneal injury in penetrating anterior chest trauma. Journal of Ultrasound in Medicine: Official Journal of the American Institute of Ultrasound in Medicine 23(4): 467-472
Shelton, E.; Rice, M.E. 1958: Studies on mouse lymphomas. III. Behavior of tumor- and non-tumor-cell populations during growth of three ascites lymphomas. Journal of the National Cancer Institute 21(1): 163-191
Warren, K.; Moberg, D.Paul.; McDonald, L. 2006: FAST and the arms race: the interaction of group aggression and the families and schools together program in the aggressive and delinquent behaviors of inner-city elementary school students. Journal of Primary Prevention 27(1): 27-45
Brooks, A.J.; Price, V.; Simms, M. 2005: FAST on operational military deployment. Emergency Medicine Journal: Emj 22(4): 263-265
Clontz, A.S.; Tasota, F.J. 2004: FAST results: using focused assessment with sonography for trauma. Nursing 34(2): 21
Sztajnkrycer, M.D.; Baez, A.Alejandro.; Luke, A. 2006: FAST ultrasound as an adjunct to triage using the START mass casualty triage system: a preliminary descriptive system. Prehospital Emergency Care: Official Journal of the National Association of Ems Physicians and the National Association of State Ems Directors 10(1): 96-102
Anonymous 1960: FASTER health clearance at airports. Medical Times 88: 144a; passim
Anonymous 1958: FASTING and in vitro liver protein release. Nutrition Reviews 16(6): 183-185
Anonymous 1959: FASTING in human obesity. Nutrition Reviews 17: 293-294
Anonymous 1956: FASTING, oxygen poisoning and radiation injury. Nutrition Reviews 14(3): 90-91
Packard, M.; Mathew, D.; Budnik, V. 2003: FASt remodeling of synapses in Drosophila. Current Opinion in Neurobiology 13(5): 527-534
Anonymous 1954: FAT ABSORPTION in absence of bile and pancreatic juice. Nutrition Reviews 12(1): 28-30
Anonymous 1956: FAT ABSORPTION in man. Nutrition Reviews 14(7): 200-201
Izenstark, J.L.; Jaffe, H.L.; Krohn, L. 1957: Postoperative radiation therapy for ovarian cancer; indications for newer types of irradiation. Obstetrics and Gynecology 9(2): 111-122
Anonymous 1957: FAT ABSORPTION studies with I 131 labeled fat meal. Nutrition Reviews 15(6): 171-172
Anonymous 1957: FAT AND nitrogen absorption in gastrectomized patients. Nutrition Reviews 15(8): 230-231
Anonymous 1956: FAT AND plasma lipids. Nutrition Reviews 14(4): 107-108
Anonymous 1956: FAT DEPOSITION in coronary arteries of rats exposed to cold. Nutrition Reviews 14(9): 284-285
Anonymous 1957: FAT DIGESTION in man. Nutrition Reviews 15(1): 7-8
Wukasch, D.C..; Malloy, K.P..; Rubio, P.A..; Reed, C.C..; Sandiford, F.M..; Allred, J.C..; Milam, J.D.. 1974: Fat Embolization Resulting from Median Sternotomy: A Preliminary Report. Cardiovascular diseases 1(1): 24-31
Anonymous 1957: FAT SOLUBLE vitamins and atherosclerosis. Nutrition Reviews 15(4): 119-121
Anonymous 1950: FAT absorption in the premature infant. Nutrition Reviews 8(11): 349-350
Anonymous 1951: FAT and blood coagulation. Nutrition Reviews 9(11): 325-326
Anonymous 1953: FAT deficiency and endocrine function. Nutrition Reviews 11(10): 308-309
Gould, W.L. 1953: A new diet aid. Medical Times 81(9): 614-615
Veslot, J.; Browaeys, J.; Pedrono, J.; Wallon, D. 1953: Value of the eosinophil count in toxicoses of the suckling infant. Le Nourrisson 41(2): 69-71
Anonymous 1952: FAT-embolism. Lancet 1(6700): 196-197
Lim, C.-B.; Zhang, D.; Lee, C.G.L. 2006: FAT10, a gene up-regulated in various cancers, is cell-cycle regulated. Cell Division 1: 20
Engelke, L.; Winter, G.; Engert, J. 2018: Application of water-soluble polyvinyl alcohol-based film patches on laser microporated skin facilitates intradermal macromolecule and nanoparticle delivery. European Journal of Pharmaceutics and Biopharmaceutics: Official Journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik E.V 128: 119-130
Anonymous 1958: FATAL agranulocytosis after novalgin. British Medical Journal 2(5096): 644-645
Anonymous 1951: FATAL anthisan poisoning. British Medical Journal 2(4746): 1530
Anonymous 1952: FATAL aplastic anemias form chloramphenicol. New England Journal of Medicine 247(5): 183-185
Anonymous 1951: FATAL barium meal. British Medical Journal 2(4723): 124
Anonymous 1953: FATAL bicycle accidents in the United States. Journal of the American Medical Association 152(10): 923
Anonymous 1952: FATAL blood transfusion. British Medical Journal 2(4797): 1315
Anonymous 1958: FATAL brain damage. British Medical Journal 1(5070): 571-572
Anonymous 1951: FATAL brain lesions. Lancet 2(6694): 1123
Anonymous 1952: FATAL bread crust. British Medical Journal 1(4772): 1361
Anonymous 1952: FATAL error in hospital. Lancet 2(6726): 195
Anonymous 1950: FATAL error in injection of drugs. Lancet 1(6612): 973
Anonymous 1951: FATAL hypersensitivity to penicillin. British Medical Journal 1(4717): 1269
Anonymous 1952: FATAL injection of sulphuric acid. Lancet 2(6729): 342
Anonymous 1951: FATAL missed pregnancy. British Medical Journal 1(4703): 421-422
Whitby, L. 1953: The challenge to medical education in the second half of the twentieth century. British Medical Journal 2(4834): 451-454
Hinton, J.W. 1956: Problems in the management of peptic ulcer. New York State Journal of Medicine 56(6): 917-920
Anonymous 1953: FATAL reactions to penicillin. New England Journal of Medicine 248(24): 1033-1034
Anonymous 1959: FATAL sensitization reaction following the use of pitocin. Wisconsin Medical Journal 58(6): 314
Lawrence, R.D. 1951: Types of human diabetes. British Medical Journal 1(4703): 373-375
Muttitt, E.L. 1951: Two cases of multiple myeloma treated with stilbamidine and urethane. Treatment Services Bulletin. Canada. DePartment of Veterans' Affairs 6(4): 189-196
Anonymous 1957: FATE OF adrenaline in the body. British Medical Journal 2(5055): 1226-1227
Anonymous 1953: FATE of premature children. British Medical Journal 1(4813): 775-776
Anonymous 1953: FATE of the amputee. Lancet 1(6761): 633-634
Anonymous 1952: FATE of the fat. Medical World 76(24): 649-650
Anonymous 1951: FATE of transfused leucocytes. British Medical Journal 2(4745): 1449-1450
Ramazini, B. 1953: FATHER of industrial medicine. New England Journal of Medicine 248(21): 915-916
Anonymous 1959: FATHER or uncles?. Lancet 2(7095): 165-166
Anonymous 1952: FATIGUE dissected. British Medical Journal 1(4762): 814-816
Bishop, D.G.; Still, J.L. 1961: Fatty Acid Metabolism in Serratia Marcescens I. : Oxidation of Saturated Fatty Acids by Whole cells. Journal of Bacteriology 82(3): 370-375
Anonymous 1953: FATTY acid contents of selected foods before and after cooking. Nutrition Reviews 11(8): 255-256
Anonymous 1958: FATTY acids and cholesterol metabolism. Nutrition Reviews 16(3): 81-82
Anonymous 1952: FATTY infiltration of the liver in newborn African babies. Nutrition Reviews 10(10): 297-299
Anonymous 1954: FATTY livers in amino acid deficiencies. Nutrition Reviews 12(1): 22-23
Anonymous 1955: FAULTY McGill tube causes death. British Medical Journal 1(4925): 1347-1348
Anonymous 1952: FAULTY feet. Lancet 2(6724): 73
Voytek, B. 2006: Emergent basal ganglia pathology within computational models. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 26(28): 7317-7318
Marro, K.I.; Hyyti, O.M.; Kushmerick, M.J. 2005: FAWSETS perfusion measurements in exercising skeletal muscle. Nmr in Biomedicine 18(5): 322-330
Kawasaki, Y.; Suzuki, J.; Nozawa, R.; Sakai, N.; Tannji, M.; Isome, M.; Suzuki, H.; Nozawa, Y. 2004: FB21, a monoclonal antibody that reacts with a sialic-acid-dependent carbohydrate epitope, is a marker for glomerular endothelial cell injury. American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation 44(2): 239-249
Budowle, B.; Polanskey, D. 2005: FBi mtDNA database: a cogent perspective. Science 307(5711): 845-847
Lee, D.-K.; Kang, J.-E.; Park, H.-J.; Kim, M.-H.; Yim, T.-H.; Kim, J.-M.; Heo, M.-K.; Kim, K.-Y.; Kwon, H.J.; Hur, M.-W. 2005: FBI-1 enhances transcription of the nuclear factor-kappaB (NF-kappaB)-responsive E-selectin gene by nuclear localization of the p65 subunit of NF-kappaB. Journal of Biological Chemistry 280(30): 27783-27791
You, J.; Zeng, G.L.; Liang, Z. 2005: FBP Algorithms for Attenuated Fan-Beam Projections. Inverse Problems 21(5): 1801
Mizutani, K.; Suetsugu, S.; Takenawa, T. 2004: FBP11 regulates nuclear localization of N-WASP and inhibits N-WASP-dependent microspike formation. Biochemical and Biophysical Research Communications 313(3): 468-474
Bellgard, M.; Kenworthy, W. 2003: FBSA: feature-based sequence alignment technique for very large sequences. Applied Bioinformatics 2(3): 145-150
Hagedorn, M.; Delugin, M.; Abraldes, I.; Allain, N.; Belaud-Rotureau, M.-A.; Turmo, M.; Prigent, C.; Loiseau, H.; Bikfalvi, A.éa.; Javerzat, S. 2007: FBXW7/hCDC4 controls glioma cell proliferation in vitro and is a prognostic marker for survival in glioblastoma patients. Cell Division 2: 9
Erich, J. 2004: FCC embraces consensus plan to end interference. Emergency Medical Services 33(8): 84
Anonymous 2003: FCC: cell phones must work with hearing aids. Consumer Reports 68(10): 7
Sanak, M.; Potaczek, D.P.; Mastalerz, L.; Nizankowska, E.; Szczeklik, A. 2007: FCERIA gene promoter polymorphisms: lack of association with aspirin hypersensitivity in whites. Journal of Allergy and Clinical Immunology 119(5): 1280-1281
Gatty, C.M. 2002: FCEs: to use or not to use?. Rehab Management 15(8): 16-17
Cheung, N.-K.V.; Sowers, R.; Vickers, A.J.; Cheung, I.Y.; Kushner, B.H.; Gorlick, R. 2006: FCGR2A polymorphism is correlated with clinical outcome after immunotherapy of neuroblastoma with anti-GD2 antibody and granulocyte macrophage colony-stimulating factor. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 24(18): 2885-2890
Lin, T.S.; Flinn, I.W.; Modali, R.; Lehman, T.A.; Webb, J.; Waymer, S.; Moran, M.E.; Lucas, M.S.; Farag, S.S.; Byrd, J.C. 2005: FCGR3A and FCGR2A polymorphisms may not correlate with response to alemtuzumab in chronic lymphocytic leukemia. Blood 105(1): 289-291
Tong, Y.; Jin, J.; Wu, J.-F.; Wang, Y.-G.; Wang, L.; Neppert, J.; Flesch, B. 2004: FCGR3B gene frequencies and FCGR3 gene variants in Chinese: a study in 487 Chinese individuals from Zhejiang Province. Zhonghua Yi Xue Za Zhi 84(17): 1426-1428
Yan, L.; Zhu, F.; Jin, L.; Lv, Q.; Fu, Q. 2005: FCGR3B polymorphism in three ethnic Chinese populations. Immunohematology 21(1): 25-28
Chen, X.; Sun, J.; Hu, Y.; Ye, F.; Wang, M.; Jin, Z.; Huang, Z.; Han, D. 2003: FCM detection and pathology observation of 5 mm cutting-edge of laryngocarcinoma. Lin Chuang Er Bi Yan Hou Ke Za Zhi 17(2): 86-88
Nguyen, M.N.; Shi, D.; Quek, C. 2006: FCMAC-BYY: fuzzy CMAC using Bayesian Ying-Yang learning. IEEE Transactions on Systems man and Cybernetics. Part B Cybernetics: a Publication of the IEEE Systems man and Cybernetics Society 36(5): 1180-1190
Sim, J.; Tung, W.L.; Quek, C. 2006: FCMAC-Yager: a novel Yager-inference-scheme-based fuzzy CMAC. IEEE Transactions on Neural Networks 17(6): 1394-1410
Atamas, S.P. 2003: FCP (http://fibro.biobitfield.com/fcp.php): a bioinformatic tool assisting in PubMed searches for literature on fibrosis-related cytokines. Arthritis and Rheumatism 48(7): 2083-2084
Arakawa, S. 2003: FCR mammography system with improved image quality. Nihon Hoshasen Gijutsu Gakkai Zasshi 59(6): 697-699
Widengren, J.; Thyberg, P. 2005: FCS cell surface measurements--photophysical limitations and consequences on molecular ensembles with heterogenic mobilities. Cytometry. Part A: the Journal of the International Society for Analytical Cytology 68(2): 101-112
Aleksandrin, V.V.; Ivanov, A.V.; Virus, E.D.; Bulgakova, P.O.; Kubatiev, A.A. 2018: Application of wavelet analysis to detect dysfunction in cerebral blood flow autoregulation during experimental hyperhomocysteinaemia. Lasers in Medical Science 33(6): 1327-1333
Simpson, D. 2004: FCTC: how will they keep pushing?. Tobacco Control 13(3): 216-217
Lim, A.Yu.Tang. 2005: FCU anatomy. Journal of Hand Surgery 30(4): 865
Luo, X.; Hong, T.-s.; Luo, K.; Dai, F.; Wu, W.-b.; Mei, H.-l.; Lin, L. 2016: Application of Wavelet Transform and Successive Projections Algorithm in the Non-Destructive Measurement of Total Acid Content of Pitaya. Guang Pu Xue Yu Guang Pu Fen Xi 36(5): 1345-1351
Mitka, M. 2004: FDA OKs nonprescription defibrillators. JAMA 292(15): 1809
Meadows, M. 2005: FDA Science Forum: advancing public health. Fda Consumer 39(2): 6-7
Ingerslev, J. 2004: FDA Workshop on factor VIII inhibitors held at the NIH, Bethesda, MA on 21 November 2003. Haemophilia: the official journal of the World Federation of Hemophilia 10(3): 288-289
Jeske, A.H. 2005: FDA actions to prevent prescription drug abuse. Texas Dental Journal 122(7): 634-645
Young, D. 2007: FDA advisers endorse Celebrex for juvenile rheumatoid arthritis: lack of studies in children raises safety concerns. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 64(1): 11-12
Traynor, K. 2005: FDA advisers vote against nonprescription lovastatin. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 62(5): 455-456; 460
Lenzer, J. 2005: FDA advisers warn: COX 2 inhibitors increase risk of heart attack and stroke. Bmj 330(7489): 440
Brady, C. 2006: FDA advisory committees: their purpose, how they work, and how you can become a member. American Journal of Gastroenterology 101(4): 689-691
Anonymous 2005: FDA advisory on nevirapine. AIDS treatment news 2005(409): 7
Moynihan, R. 2004: FDA advisory panel calls for suicide warnings over new antidepressants. Bmj 328(7435): 303
Young, D. 2004: FDA advisory panel discusses droperidol concerns. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 61(3): 219
Finkelstein, J.B. 2006: FDA advisory panel voices persistent safety concerns. Journal of the National Cancer Institute 98(7): 439
Anonymous 2003: FDA aims to improve and streamline the drug development and review process. Drug News and Perspectives 16(1): 40
Mitka, M. 2003: FDA alert on antidepressants for youth. JAMA 290(19): 2534
Young, D. 2004: FDA aluminum rule poses challenges for industry, pharmacists. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 61(8): 742; 744
Anonymous 2006: FDA among many groups addressing access to care. Today's Fda: Official Monthly Journal of the Florida Dental Association 18(1): 27 29
Lee, R. 2006: FDA and drug safety: new Tufts study challenges critics of the Prescription Drug User Fee Act. Journal of Law Medicine and Ethics: a Journal of the American Society of Law Medicine and Ethics 34(1): 131-134
Rein, B.W. 2005: FDA and the life-sciences industry: business as usual?". Hastings Center Report 35(2): 7; Author Reply 7
Thorley, V. 2005: Breast hypoplasia and breastfeeding: a case history. Breastfeeding Review: Professional Publication of the Nursing Mothers' Association of Australia 13(2): 13-16
Smithson, A. 2004: NEHA sinks deeper into wastewater. Journal of Environmental Health 66(9): 34
Dyer, O. 2003: FDA announces fast track approval of new drug for lung cancer. Bmj 326(7397): 1004
Anonymous 2003: FDA announces initiative to curb counterfeit drugs. Fda Consumer 37(5): 6
Tanne, J.Hopkins. 2006: FDA appointment is stalled as revelations emerge over Plan B. Bmj 333(7563): 317
Anonymous 2004: FDA approval for the antidepressive drug Cymbalta. KrankenpflegeJournal 42(5-6): 154
Nosé, Y. 2007: FDA approval of totally implantable permanent total artificial heart for humanitarian use. Artificial Organs 31(1): 1-3
Sax, P.E. 2006: FDA approval: darunavir. Aids Clinical Care 18(8): 71
Sax, P.E. 2005: FDA approval: tipranavir. Aids Clinical Care 17(8): 78
Britz, R.; Bartsch, P. 2003: The myth of dorsal ribs in gnathostome vertebrates. PROCEEDINGS. Biological Sciences 270 Suppl 1(1): S1-S4
Ginsberg, K.M. 1997: FDA approved? a critique of the artificial insemination industry in the United States. University of Michigan Journal of Law Reform. University of Michigan. Law School 30(4): 823-851
Anonymous 2003: FDA approves Gleevec for pediatric leukemia. Fda Consumer 37(4): 6
Anonymous 2004: FDA approves Hep C drugs. Aids Alert 19(6): 71
Anonymous 2003: FDA approves Lexiva. IAPAC monthly 9(11): 280
Anonymous 2003: FDA approves OTC Claritin. Fda Consumer 37(1): 3
Branson, B.M. 2004: FDA approves OraQuick for use in saliva. On March 25, the FDA approved the first rapid test for HIV in oral fluids. Aids Clinical Care 16(5): 39
Anonymous 2004: FDA approves SQV/r. Iapac Monthly 10(1): 39
DeJohn, P. 2004: FDA approves Taxus stent; materials managers cheer. Hospital Material Dollar Sign Management 29(4): 1 9
Anonymous 2006: FDA approves antidepressant drug for treatment of seasonal depression. Mayo Clinic Women's Healthsource 10(11): 3
Anonymous 2006: FDA approves early test. Aids Patient Care and Stds 20(11): 814
Anonymous 2003: FDA approves first drug in new treatment category. Aids Policy and Law 18(6): 3
Anonymous 2003: FDA approves first injectable solution for dog sterilization. FDA consumer 37(6): 3
O'Rourke, M. 2005: FDA approves generic AZT for U.S. market. Aids Clinical Care 17(11): 108
Young, D. 2004: FDA approves generic OxyContin. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 61(9): 882; 886
Anonymous 2006: FDA approves generic abacavir sulfate tablets. AIDS alert 21(12): 139-140
Anonymous 2003: FDA approves generic drug for persistent heartburn. Fda Consumer 37(1): 2
Markenson, A.J.; Adelglass, C. 2004: Navigating the hospice benefit. Provider 30(2): 35-37
Anonymous 2003: FDA approves growth hormone for short children. Child Health Alert 21: 4
Meadows, M. 2005: FDA approves heart drug for black patients. Fda Consumer 39(5): 8-9
Kornmehl, E.W. 2004: FDA approves help for aging eyes. Conductive keratoplasty may improve vision for people older than 40 who need reading glasses to see "the fine print". Health News 10(6): 8-9
Hopkins Tanne, J. 2004: FDA approves implantable chip to access medical records. Bmj 329(7474): 1064
Cuzzell, J.Zeigler. 2005: FDA approves mandatory risk management program for isotretinoin. Dermatology Nursing 17(5): 383
Nagaratnam, N.; Bou-Haidar, P.; Leung, H. 2003: Confused and disturbed behavior in the elderly following silent frontal lobe infarction. American Journal of Alzheimer's Disease and other Dementias 18(6): 333-339
Gadd, C. 2006: FDA approves new Pi. Iapac Monthly 12(6): 174
Traynor, K. 2007: FDA approves new antipsychotic. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 64(3): 222
Anonymous 2006: FDA approves new hip resurfacing system. Health News 12(7): 2
Anonymous 2003: FDA approves new oral contraceptive. FDA consumer 37(6): 5
Anonymous 2006: FDA approves new rotavirus vaccine...and hope for a bird flu vaccine?. Child Health Alert 24: 1-2
Selnes, O.A. 2005: Memory loss in persons with HIV/AIDS: assessment and strategies for coping. Aids Reader 15(6): 289-292; 294
Johansson, S.G.O. 2004: ImmunoCAP Specific IgE test: an objective tool for research and routine allergy diagnosis. Expert Review of Molecular Diagnostics 4(3): 273-279
Corbella Jané, A.; Maturana Domínguez, S. 2002: Citizens' role in health services: satisfaction behavior: Kano's model, Part 2. Quality Management in Health Care 12(1): 72-80
Anonymous 2003: FDA approves rapid-result HIV test kit. Dentistry Today 22(1): 24
Mathias, J.M.; Patterson, P. 2006: FDA approves second lumbar artificial disc. Or Manager 22(11): 23; 25
Mitka, M. 2006: FDA approves shingles vaccine: herpes zoster vaccine targets older adults. JAMA 296(2): 157-158
Tanne, J.H. 2006: FDA approves silicone breast implants 14 years after their withdrawal. Bmj 333(7579): 1139
Anonymous 2003: FDA approves test for heart-disease marker. Health News 9(10): 10
Anonymous 2005: FDA approves tipranavir. IAPAC monthly 11(7): 190
Anonymous 2004: FDA approves treatment for facial fat loss. Aids Alert 19(10): 119-120
Lu, Y.; Xie, H. 2017: Application of Wearable Devices in Medical Field. Zhongguo Yi Liao Qi Xie Za Zhi 41(3): 213-215
Anonymous 2004: FDA approves two combo brand-name AIDS drugs. Medicine and Health 58(31): 3-4
Ringold, S. 2004: FDA approves ultrasound fibroid therapy. JAMA 292(23): 2826
Lang, L.H. 2006: FDA approves use of bacteriophages to be added to meat and poultry products. Gastroenterology 131(5): 1370
Anonymous 2005: FDA asks Purdue Pharma to withdraw Palladone. FDA consumer 39(5): 7
Lenzer, J. 2004: FDA bars own expert from evaluating risks of painkillers. Bmj 329(7476): 1203
Lewis, C. 2003: FDA begins product approval initiative. Fda Consumer 37(3): 10-11
Rados, C. 2004: FDA cautions against ultrasounds 'keepsake' images. Fda Consumer 38(1): 12-16
Anonymous 2004: FDA cautions breast-feeding moms. Fda Consumer 38(5): 6
Kennedy, D. 2006: FDA centennial. Science 312(5770): 19
Webster, P. 2003: FDA chief attacks Canada's drug price controls. Lancet 362(9398): 1816
Hopkins Tanne, J. 2003: FDA chief wants other rich countries to share drug development costs. Bmj 327(7419): 830
Young, D. 2003: FDA clarifies importation law as Internet pharmacies proliferate. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 60(8): 729-730
Mahy, B.W.J. 2006: A new pathogenic human parvovirus. Reviews in Medical Virology 16(5): 279-280
Walczak, I.M. 2003: FDA clears home glycated hemoglobin test for diabetics. Diabetes Technology and Therapeutics 5(1): 124
Opelz, G. 1992: Strength of HLA-A, HLA-B, and HLA-DR mismatches in relation to short- and long-term kidney graft survival. Collaborative Transplant Study. Transplant International: Official Journal of the European Society for Organ Transplantation 5 Suppl 1(5): S621-S624
Charatan, F. 2006: FDA committee votes for warning labels on stimulant drugs. Bmj 332(7538): 380
Rados, C. 2004: Science meets beauty: using medicine to improve appearances. Fda Consumer 38(2): 30-35
Anonymous 2003: FDA debuts drug product catalog. Aids Patient Care and Stds 17(7): 370
Pitts, P. 2004: FDA decision making. Health Affairs 23(3): 287; Author Reply 287-8
Young, D. 2004: FDA declares actions to combat counterfeit drugs. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 61(7): 645
Ault, A. 2004: FDA demands more information about breast implants. Lancet 363(9404): 218
Lawson, G.W. 2005: FDA dependence on drug industry. Journal of the National Medical Association 97(7): 1039-1040
Anonymous 2006: FDA discusses studies to support OTC HIV test kits. Aids Alert 21(4): 45-47
Revicki, D.A. 2007: FDA draft guidance and health-outcomes research. Lancet 369(9561): 540-542
Donawa, M.E. 2005: FDA draft guidance on computerised systems used in clinical trials. Medical Device Technology 16(1): 24-27
Ibrahim, A.; Hirschfeld, S.; Cohen, M.H.; Griebel, D.J.; Williams, G.A.; Pazdur, R. 2004: FDA drug approval summaries: oxaliplatin. Oncologist 9(1): 8-12
Hazarika, M.; White, R.M.; Johnson, J.R.; Pazdur, R. 2004: FDA drug approval summaries: pemetrexed (Alimta). Oncologist 9(5): 482-488
Kaminskas, E.; Farrell, A.T.; Wang, Y-Cheng.; Sridhara, R.; Pazdur, R. 2005: FDA drug approval summary: azacitidine (5-azacytidine, Vidaza) for injectable suspension. Oncologist 10(3): 176-182
Cohen, M.H.; Johnson, J.R.; Chen, Y-Fong.; Sridhara, R.; Pazdur, R. 2005: FDA drug approval summary: erlotinib (Tarceva) tablets. Oncologist 10(7): 461-466
Cohen, M.H.; Williams, G.A.; Sridhara, R.; Chen, G.; Pazdur, R. 2003: FDA drug approval summary: gefitinib (ZD1839) (Iressa) tablets. Oncologist 8(4): 303-306
Cohen, M.H.; Johnson, J.R.; Wang, Y-Cheng.; Sridhara, R.; Pazdur, R. 2005: FDA drug approval summary: pemetrexed for injection (Alimta) for the treatment of non-small cell lung cancer. Oncologist 10(6): 363-368
Wagner, A.K.; Chan, K.A.; Dashevsky, I.; Raebel, M.A.; Andrade, S.E.; Lafata, J.E.; Davis, R.L.; Gurwitz, J.H.; Soumerai, S.B.; Platt, R. 2006: FDA drug prescribing warnings: is the black box half empty or half full?. Pharmacoepidemiology and Drug Safety 15(6): 369-386
Kurtz, D.L. 1958: FDA drug reaction reporting program. Hospitals 32(12): 49-52
Tanne, J.H. 2005: FDA ducks decision on emergency contraceptive. Bmj 331(7517): 596
Anonymous 2006: FDA electronic drug labels to improve patient safety. Journal of Pain and Palliative Care PharmacoTherapy 20(2): 96-97
Young, D. 2004: FDA embraces RFID to protect drug supply. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 61(24): 2612; 2615
Anonymous 2004: FDA evaluating new angina drug. Health News 10(3): 7
Powers, J.H.; Lin, D.; Ross, D. 2005: FDA evaluation of antimicrobials: subgroup analysis. Chest 127(6): 2298-9; authore reply 2300-1
Young, D. 2003: FDA examines direct-to-consumer advertising data. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 60(23): 2420 2422 2424 Passim
Wakefield, J. 2004: FDA eyes pharmacogenomics data. Environmental Health Perspectives 112(4): A217
Tanne, J.H. 2006: FDA finally approves Plan B--but with restrictions. Bmj 333(7566): 461
Ault, A. 2004: FDA follows NIH in review of staff consulting activities. Lancet 363(9423): 1779
Anonymous 2004: FDA grants approval to fosamprenavir calcium. Aids Alert 19(1): 11-12
Williams, D.A. 2005: FDA guidance document on monitoring delayed adverse events a good first start. Molecular Therapy: the Journal of the American Society of Gene Therapy 12(6): 991-992
Schultz, J. 2003: FDA guidelines on race and ethnicity: obstacle or remedy?. Journal of the National Cancer Institute 95(6): 425-426
Anonymous 2004: FDA guidelines revised for combination HIV therapies. Aids Policy and Law 19(10): 2
Pollack, A. 2003: FDA halts 27 gene therapy trials after illness: leukemia-like cases in 2 children in France prompt the action. New York Times on the Web 2003: A1 A17
Neil, R. 2006: FDA has a change of heart. Materials Management in Health Care 15(5): 9
Huff, B. 2005: FDA hearing on home HIV testing. Gmhc Treatment Issues: the Gay Men's Health Crisis Newsletter of Experimental Aids Therapies 19(12): 9
Ault, A. 2003: FDA homes in on counterfeit and imported drugs. Lancet 362(9391): 1208
Hopkins Tanne, J. 2003: FDA imposes tougher rules on imported foods. Bmj 327(7414): 522
Thompson, C.A. 2004: FDA improves communication about drug shortages. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 61(9): 880 882
Bren, L. 2005: Straight talk on braces. Fda Consumer 39(1): 20-26
Liang, J.-W.; Fang, Z.-Y.; Huang, Y.; Liuyang, Z.-Y.; Zhang, X.-L.; Wang, J.-L.; Wei, H.; Wang, J.-Z.; Wang, X.-C.; Zeng, J.; Liu, R. 2018: Application of Weighted Gene Co-Expression Network Analysis to Explore the Key Genes in Alzheimer's Disease. Journal of Alzheimer's Disease: Jad 65(4): 1353-1364
Lenzer, J. 2005: FDA investigates direct to consumer adverts. Bmj 331(7525): 1102
Lenzer, J. 2004: FDA is incapable of protecting US "against another Vioxx". Bmj 329(7477): 1253
Baughman, R.; Cook, L.; Lanham, J. 2003: Testing your diagnostic skills. Case no. 1. Melanotic macule. Today's Fda: Official Monthly Journal of the Florida Dental Association 15(10): 20; 22
Nelson, R. 2004: FDA issues alert on ephedra supplements in the USA. Lancet 363(9403): 135
Anonymous 2005: FDA issues final guidance on nucleic acid tests. Aids Alert 20(4): 46-47
Anonymous 2006: FDA issues guidance about HIV vaccine study. Aids Alert 21(6): 71
Meadows, M. 2003: FDA issues guidance on race and ethnicity data. Fda Consumer 37(3): 36
González-Lahoz, J. 2004: FDA issues labeling changes for efavirenz. Aids Reviews 6(3): 181-182
Greene, J. 2005: Scan your patient to verify surgical site. Or Manager 21(1): 7
Anonymous 2004: FDA issues new rules on donor tissue eligibility. Molecular therapy: the journal of the American Society of Gene Therapy 10(1): 3-4
Anonymous 2003: FDA issues new security guidance: Operation Liberty Shield. Public Health Reports 118(3): 276
Sikora, K. 2005: Molecular diagnostics: new applications and technologies - accelerating drug development. Expert Review of Molecular Diagnostics 5(3): 279-280
Anonymous 2005: FDA issues public health advisory recommending limited use of COX-2 inhibitors. South African Medical Journal 95(2): 92
Anonymous 2004: FDA issues warning letter to Abbott over Norvir pricing spin. GMHC treatment issues: the Gay Men's Health Crisis newsletter of experimental AIDS therapies 18(5-6): 11
Meadows, M. 2003: FDA issues warning on decorative contact lenses. Fda Consumer 37(1): 18-19
Mitka, M. 2003: FDA issues warning on "all-natural" herbal product found to contain viagra. JAMA 289(21): 2786
Yoon, E.Y.; Davis, M.M.; El-Essawi, H.; Cabana, M.D. 2006: FDA labeling status of pediatric medications. Clinical Pediatrics 45(1): 75-77
Young, D. 2005: FDA labors over NSAID decisions: panel suggests COX-2 inhibitors stay available. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 62(7): 668-672
Rados, C. 2004: Ephedra ban: no shortage of reasons. Fda Consumer 38(2): 6-7
Young, D. 2003: FDA launches new initiative to battle counterfeit drugs. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 60(17): 1712; 1715, 1720
Rados, C. 2006: FDA law enforcement: critical to product safety. Fda Consumer 40(1): 21-27
Anonymous 2003: FDA licensure of diphtheria and tetanus toxoids and acellular pertussis adsorbed, hepatitis B (recombinant), and poliovirus vaccine combined, (PEDIARIX) for use in infants. Mmwr. Morbidity and Mortality Weekly Report 52(10): 203-204
Anonymous 2006: FDA makes final approvals. Aids Patient Care and Stds 20(5): 381
Runner, S. 2006: FDA marketing claims, and the practitioner. Journal of Evidence-Based Dental Practice 6(1): 19-23
Carlson-Easley, N. 2004: FDA members make Give Kids a Smile a success. Today's Fda: Official Monthly Journal of the Florida Dental Association 16(4): 44-45
Anonymous 2006: FDA milestones. Fda Consumer 40(1): 36-38
Ault, A. 2003: FDA moves to curb drug counterfeiting. Lancet 362(9380): 301
Christie, B. 2005: FDA needs more sophisticated approach to drug safety. Bmj 330(7501): 1166
Wynn, R.L. 2004: FDA new drug approvals in 2003. General Dentistry 52(4): 294-298; 300
Wynn, R.L. 2005: FDA new drug approvals in 2004. General Dentistry 53(4): 246-248
Wynn, R.L. 2006: FDA new drug approvals in 2005. General Dentistry 54(4): 230-233
Anonymous 2003: FDA news. Price criticized for new anti-HIV drug. Aids Alert 18(5): 67-68
Anonymous 2005: FDA notifications. Accelerated approval of tipranavir. Aids Alert 20(11): 131
Anonymous 2005: FDA notifications. Adult treatment guidelines updated. Aids Alert 20(11): 130-131
Anonymous 2005: FDA notifications. BMS issues letter about omeprazole. Aids Alert 20(4): 45-46
Anonymous 2005: FDA notifications. Entecavir is approved for chronic hepatitis B infection in adults. Aids Alert 20(7): 83-84
Anonymous 2003: FDA notifications. FDA approves Fuzeon, the first fusion inhibitor. Aids Alert 18(6): 78-79
Anonymous 2005: FDA notifications. FDA approves generic foscarnet sodium injection. Aids Alert 20(7): 82
Anonymous 2005: FDA notifications. FDA approves new Kaletra formulation. AIDS alert 20(12): 142-143
Anonymous 2005: FDA notifications. FDA approves pediatric dosing for ritonavir. Aids Alert 20(11): 129-130
Anonymous 2006: FDA notifications. FDA grants tentative approval to generic Nevirapine. Aids Alert 21(2): 23-24
Anonymous 2006: FDA notifications. FDA grants tentative approval to generic stavudine. Aids Alert 21(2): 24
Anonymous 2005: FDA notifications. FDA provides important information for clinicians serving hurricane victims. Aids Alert 20(11): 129
Anonymous 2003: FDA notifications. FDA uncovers counterfeit Procrit. Aids Alert 18(6): 79-80
Anonymous 2005: FDA notifications. Generic lamivudine tentatively approved. AIDS alert 20(12): 142
Anonymous 2003: FDA notifications. Gilead issues letter about virologic failure. Aids Alert 18(12): 159-160
Anonymous 2006: FDA notifications. HIV/AIDS patients should avoid raw oysters from Pacific NW. Aids Alert 21(9): 105-107
Anonymous 2003: FDA notifications. Labeling rule proposed for dietary supplements. Aids Alert 18(7): 90-91
Anonymous 2003: FDA notifications. NRTI Emtriva receives FDA approval. Aids Alert 18(10): 131-132
Anonymous 2005: FDA notifications. New antiretroviral guidelines issued. Aids Alert 20(1): 11-12
Anonymous 2003: FDA notifications. New dosing option approved for Viracept. Aids Alert 18(7): 90
Anonymous 2003: FDA notifications. New labeling for N-9 products?. Aids Alert 18(3): 40
Anonymous 2004: FDA notifications. New web page launched for HIV drug deliberations. Aids Alert 19(10): 120
Anonymous 2003: FDA notifications. Nutrition management essential for HIV infection. Aids Alert 18(6): 77-78
Anonymous 2004: FDA notifications. Oral fluid-based rapid HIV test approved. Aids Alert 19(6): 71-72
Anonymous 2005: FDA notifications. Pediatric HIV infection guidelines updated. Aids Alert 20(7): 83
Anonymous 2002: FDA notifications. Product tampering labels Ziagen as Combivir. AIDS alert 17(8): 102
Anonymous 2006: FDA notifications. Proposed changes to condom regulations. Aids Alert 21(1): 10-11
Anonymous 2003: FDA notifications. Reyataz is approved for HIV treatment. Aids Alert 18(9): 119-120
Anonymous 2005: FDA notifications. Roche issues letter about saquinavir. Aids Alert 20(7): 84
Anonymous 2005: FDA notifications. Tentative approval of India-made zidovudine. Aids Alert 20(9): 108
Anonymous 2004: FDA notifications. UCB Pharma and FDA issue advisory letter. Aids Alert 19(2): 22-24
Anonymous 2002: FDA notifications. Watch out for counterfeit Procrit, 2 lot numbers. AIDS alert 17(8): 101-102
Moynihan, R. 2003: FDA officials argue over safety of new arthritis drug. Bmj 326(7389): 565
Stephenson, J. 2003: FDA orders estrogen safety warnings: agency offers guidance for HRT use. JAMA 289(5): 537-538
Moynihan, R. 2005: FDA panel approves one make of silicone breast implant in the US. Bmj 330(7497): 919
Kuehn, B.M. 2007: FDA panel seeks to balance risks in warnings for antidepressants. JAMA 297(6): 573-574
Lenzer, J. 2004: FDA panel urges "black box" warning for antidepressants. Bmj 329(7468): 702
Kuehn, B.M. 2005: FDA panel: keep COX-2 drugs on market: black box for COX-2 labels, caution urged for all NSAIDs. JAMA 293(13): 1571-1572
Chen, E.; Sapirstein, W.; Ahn, C.; Swain, J.; Zuckerman, B. 2006: FDA perspective on clinical trial design for cardiovascular devices. Annals of Thoracic Surgery 82(3): 773-775
Harper, C.C.; Philip, R.; Robinowitz, M.; Gutman, S.I. 2005: FDA perspectives on pharmacogenetic testing. Expert Review of Molecular Diagnostics 5(5): 643-648
Tezak, Z.; Ranamukhaarachchi, D.; Russek-Cohen, E.; Gutman, S.I. 2006: FDA perspectives on potential microarray-based clinical diagnostics. Human Genomics 2(4): 236-243
Kim, M-Jin. 2005: FDA perspectives on supplement use by patients on antithrombotic therapy. Thrombosis Research 117(1-2): 197-200; Discussion 201-7
Woo, J.J.Y. 2005: FDA perspectives on supplement use by patients on antithrombotic therapy: dietary supplement regulatory overview. Thrombosis Research 117(1-2): 193-6; Discussion 201-7
Donawa, M.E. 2003: FDA pilot programme in support of global harmonisation. Medical Device Technology 14(9): 32-34
Morris, K. 2004: FDA plans warning labels for condoms. Lancet. Infectious Diseases 4(5): 257
Young, D. 2006: FDA ponders cardiovascular risks of ADHD drugs. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 63(6): 492-494
Young, D. 2005: FDA ponders future of NSAIDs: Pfizer reluctantly withdraws Bextra. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 62(10): 997; 1000
Klein, D.F. 2006: FDA post-marketing safety decisions. Journal of Clinical Psychiatry 67(8): 1305-1306
Roehr, B. 2007: FDA proposes changes in access and charges for experimental drugs. Bmj 334(7583): 12
Tanne, J.Hopkins. 2007: FDA proposes higher fees for drug approvals to cover postmarketing surveillance. Bmj 334(7586): 177
Reeder, L. 2003: Exploring a new alternative to hospital/physician joint ventures. Healthcare Leadership and Management Report 11(2): 1-5
Kerlan, I. 1957: FDA protection and the dentist: a review and forecast. Journal of the American Dental Association 55(1): 76-82
Kerlan, I. 1957: FDA protection and the dermatolgist. A.M.A. Archives of Dermatology 76(1): 87-90
Kerlan, I. 1962: FDA protection and the healing arts. Federation Bulletin 49: 303-318
Oransky, I. 2003: FDA questions antidepressant safety for children. Lancet 362(9395): 1558
Merrill, R.A.; Rose, B.J. 2001: FDA regulation of human cloning: usurpation or statesmanship?. Harvard journal of law & technology 15(1): 85-148
Halme, D.Gould.; Kessler, D.A. 2006: FDA regulation of stem-cell-based therapies. New England Journal of Medicine 355(16): 1730-1735
Ogden, N. 2003: FDA regulation of technology and surgical devices in the operating room. Seminars in Laparoscopic Surgery 10(3): 115-119
Siegel, M.; Blum, A. 2006: FDA regulation of tobacco: reprieve for the Marlboro man?. Lancet 368(9532): 266-268
Rados, C. 2004: FDA reiterates warning against online drug buying. Fda Consumer 38(5): 17
Tanne, J.H. 2006: FDA rejected contraception for political reasons. Bmj 332(7542): 624
Tanne, J.H. 2004: FDA rejects over the counter status for emergency contraceptive. Bmj 328(7450): 1219
Dyer, O. 2005: FDA rejects sale of over the counter statins. Bmj 330(7484): 164
Runowicz, C.D. 2003: I've heard that lymphedema can develop after cancer treatment. what is lymphedema, and how is it treated?. Health News 9(3): 12
Capilla Montes, C.; Bermejo Vicedo, T. 2005: Efficacy and safety of misoprostol in obstetrics. Farmacia Hospitalaria: Organo Oficial de Expresion Cientifica de la Sociedad Espanola de Farmacia Hospitalaria 29(3): 177-184
Christensen, D.E. 2003: FDA reorganization intended to streamline review process for biologics. Journal of the National Cancer Institute 95(8): 576-577
Bonito, A.J.; Lux, L.; Lohr, K.N. 2005: Impact of local adjuncts to scaling and root planing in periodontal disease therapy: a systematic review. Journal of Periodontology 76(8): 1227-1236
Neugebauer, J.ör.; Traini, T.; Thams, U.; Piattelli, A.; Zöller, J.E. 2006: Peri-implant bone organization under immediate loading state. Circularly polarized light analyses: a minipig study. Journal of Periodontology 77(2): 152-160
Anonymous 2006: FDA report shows how company missed toxin that killed dogs. Journal of the American Veterinary Medical Association 228(6): 829
Tillett, T. 2006: Beyond the bench: tracking clues with environmental health sleuths. Environmental Health Perspectives 114(3): A158-A159
Traynor, K. 2006: FDA resurrects, finalizes labeling rule. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 63(5): 398; 400
Finkelstein, J.B. 2006: FDA revamps committee conflict-of-interest rules. Journal of the National Cancer Institute 98(19): 1354-1355
Vastag, B. 2004: FDA reviews expanded claims on health benefits of certain foods. Journal of the National Cancer Institute 96(16): 1198-1199
Young, D. 2005: FDA revisits DTC advertising. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 62(24): 2580 2582-3
Meyer, G.A. 2004: FDA rules for R&D also: root cause analysis and failure investigations. Conference Proceedings: . Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference 2004: 5140
Ault, A. 2003: FDA says it will require trans-fat amounts on food labels. Lancet 362(9379): 218
Rados, C. 2004: FDA science: from concept to consumer. Fda Consumer 38(3): 10-11
Bren, L. 2003: FDA science: protecting America's health. Fda Consumer 37(2): 30-35
Hampton, T. 2004: FDA seeks genome-based drug data. JAMA 291(1): 32-33
Roehr, B. 2005: FDA seeks to ease burden on trial review boards. Bmj 330(7494): 748
Anonymous 2006: FDA shares data on events related to the reuse of single-use devices. Or Manager 22(11): 1 14-5 17
Charatan, F. 2006: FDA shuts down human tissue company. Bmj 332(7540): 507
Mathews, A.W. 2006: FDA signals it's open to drug trials that shift midcourse. Wall Street Journal 2006: B1 B8
Kuehn, B.M. 2006: FDA speeds smoking cessation drug review. JAMA 295(6): 614
Avorn, J. 2005: FDA standards--good enough for government work?. New England Journal of Medicine 353(10): 969-972
Yang, H.; Liu, J.; Zhang, X.; Shi, X.; Jiang, B.; Xu, S.; Wang, J. 2017: Application of Whole Body Localization Technique in the Craniospinal Intensity-modulated Radiotherapy. Zhongguo Yi Liao Qi Xie Za Zhi 41(4): 302-305
Hutt, P.Barton. 2005: FDA statutory authority to regulate the safety of dietary supplements. American Journal of Law and Medicine 31(2-3): 155-174
Anonymous 2005: FDA still faces questions on drug safety. Medicine and Health 59(6 Spec No.): 9-11
Stokowski, L.A. 2005: FDA strengthens labeling for long-acting penicillins. Advances in Neonatal Care: Official Journal of the National Association of Neonatal Nurses 5(3): 123-124
Anonymous 2005: FDA symbolically stigmatizes gay donors with new rules. Aids Policy and Law 20(10): 1 4
Young, D. 2007: FDA targets unapproved drugs. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 64(4): 347-348
Coombes, R. 2007: FDA tightens its grip on drug regulation. Bmj 334(7588): 290-291
Ling, A.M. 2004: FDA to ban sales of dietary supplements containing ephedra. Journal of Law Medicine and Ethics: a Journal of the American Society of Law Medicine and Ethics 32(1): 184-186
Tanne, J.Hopkins. 2006: FDA to clarify rules on advisory committee members. Bmj 333(7562): 278
Traynor, K. 2004: FDA to require bar coding of most pharmaceuticals by mid-2006. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 61(7): 644-645
Anonymous 2004: FDA to require dementia warning on hormones. Health News 10(4): 5
Lenzer, J. 2005: FDA to review "missing" drug company documents. Bmj 330(7481): 7
Burton, T. 2006: FDA to weigh test of blood substitute out of public view. Wall Street Journal 2006: D3
Burton, T.M. 2006: FDA to weigh using fake blood in trauma trial. Wall Street Journal 2006: B1 B2
St John, B.; Grossbauer, S. 2006: FDA unveils food safety update. Provider 32(3): 57-59
Altiparmak, M.R.; Pamuk, O.N.; Fresko, I. 2004: Massive hematuria in rheumatoid arthritis: an unusual manifestation of reactive amyloidosis. Clinical and Experimental Rheumatology 21(6): 799-800
Kondro, W. 2004: FDA urges "black box" warning on pediatric antidepressants. Cmaj: Canadian Medical Association Journal 171(8): 837-838
Donawa, M. 2002: FDA user fee and Modernisation Act. Medical Device Technology 13(10): 27-29
Anonymous 2005: FDA warning on NSAID use. Fda Consumer 39(2): 5
Anonymous 2004: FDA warning on unapproved performance enhancer. Fda Consumer 38(1): 4
Charatan, F. 2006: FDA warns US consumers not to eat spinach after e coli outbreak. Bmj 333(7570): 673
Anonymous 2005: FDA warns about Elidel, Protopic. Child Health Alert 23: 6
Anonymous 2002: FDA warns about counterfeit Epogen. AIDS alert 17(8): 102-103
Anonymous 2003: FDA warns about counterfeit drug. Aids Patient Care and Stds 17(5): 258
Lenzer, J. 2005: FDA warns about using antipsychotic drugs for dementia. Bmj 330(7497): 922
Hampton, T. 2004: FDA warns against breast milk drug. JAMA 292(3): 322
Tanne, J.H. 2004: FDA warns against commercial prenatal ultrasound videos. Bmj 328(7444): 853
Meadows, M. 2004: New prescription drug safety plan. Fda Consumer 38(3): 7
Kuehn, B.M. 2005: FDA warns antipsychotic drugs may be risky for elderly. JAMA 293(20): 2462
Anonymous 2003: FDA warns consumers about star anise teas. FDA consumer 37(6): 4
Dobson, R. 2004: FDA warns of risks from breast implants. Bmj 328(7452): 1338
Stephenson, J. 2004: FDA warns on mercury in tuna. JAMA 291(2): 171
Lenzer, J. 2005: FDA warns that antidepressants may increase suicidality in adults. Bmj 331(7508): 70
Shwe, T.-T.-W.; Yamamoto, S.; Kakeyama, M.; Kobayashi, T.; Fujimaki, H. 2005: Effect of intratracheal instillation of ultrafine carbon black on proinflammatory cytokine and chemokine release and mRNA expression in lung and lymph nodes of mice. Toxicology and Applied Pharmacology 209(1): 51-61
Anonymous 2004: FDA white paper offers solution to therapy pipeline problem. Gastroenterology 126(7): 1652
Tanne, J.H. 2004: FDA will increase postmarketing surveillance of drugs. Bmj 329(7476): 1203
Lenzer, J. 2005: FDA wins spoof award for its "collusion" with the drug industry. Bmj 330(7491): 555
Rados, C. 2003: FDA works to reduce preventable medical device injuries. Fda Consumer 37(4): 29-33
Meyer, R.J. 2003: FDA "black box" labeling. Annals of Emergency Medicine 41(4): 559-560
Traynor, K. 2005: FDA's adverse-event surveillance needs improvement, advisers say. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 62(13): 1336 1338 1340
Bartoo, G. 2005: FDA's annual report on medical devices. IEEE Engineering in Medicine and Biology Magazine: the Quarterly Magazine of the Engineering in Medicine and Biology Society 24(1): 99-100
Lenzer, J. 2004: FDA's counsel accused of being too close to drug industry. Bmj 329(7459): 189
O'Neill, R.T. 2006: FDA's critical path initiative: a perspective on contributions of biostatistics. Biometrical Journal. Biometrische Zeitschrift 48(4): 559-564
Merkatz, R.B. 2005: FDA's decision on Plan B: a surrogate for lack of commitment to women's health. Journal of Women's Health 14(9): 860
Young, D. 2005: FDA's drug safety initiative: resolutions or more questions? Regulators defend past actions, future plans. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 62(13): 1333-4 1336
Young, D. 2006: FDA's monitoring of postmarketing studies probed. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 63(16): 1485-1486
Hui, Y.F. 2003: FDA's proposed rules on patent listing requirements for new drug and 30-month stays on ANDA approval (proposed Oct. 24, 2002). Annals of Health Law 12(2): 325-340 Table of Contents
Bren, L. 2003: FDA's response to food, dietary supplement, and cosmetic adverse events. Fda Consumer 37(4): 12-13
Moynihan, R. 2005: FDA's safety reform is greeted with scepticism. Bmj 330(7489): 435
Rados, C. 2003: FDA, Red Cross reach agreement to improve blood safety. Fda Consumer 37(4): 34-35
Anonymous 2004: FDA, alliance work to improve health information access. Fda Consumer 38(5): 7
James, J.S. 2005: FDA, companies test RFID tracking to prevent drug counterfeiting. Aids Treatment News 2005(417): 5-8
Klaus, B.D. 2003: FDA-approved home HIV test available nationwide. Nurse Practitioner 28(3): 65
Curts, C. 2007: FDA-regulated validation in clinical and nonclinical environments. IEEE Engineering in Medicine and Biology Magazine: the Quarterly Magazine of the Engineering in Medicine and Biology Society 26(1): 91
Couzin, J. 2006: FDA. Proposed guidelines for emergency research aim to quell confusion. Science 313(5792): 1372-1373
Kerlan, I. 1960: FDA... Physician protection of foods, drugs, devices, and cosmetics. Medical Times 88: 1431-1439
Katz, R. 2004: FDA: evidentiary standards for drug development and approval. Neurorx: the Journal of the American Society for Experimental Neurotherapeutics 1(3): 307-316
Curry, J. 2003: FDA: global citizen. Gmhc Treatment Issues: the Gay Men's Health Crisis Newsletter of Experimental Aids Therapies 17(9): 12
McClellan, M.B. 2004: FDA: protecting and advancing America's health. Health Matrix 14(2): 357-370
Young, D. 2006: FDA: regulations will clarify pedigree requirements: loopholes remain in PDMA law. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 63(14): 1306; 1310, 1312
Anonymous 2006: FDA: so-called 'Canadian' products really from other countries. Fda Consumer 40(2): 3
Bauknecht, A.J. 2001: FDAS returns profit to members, makes service primary goal. Today's Fda: Official Monthly Journal of the Florida Dental Association 13(2): 16-17
Rouëssé, J.; Alberini, J.-L.; Wartski, M.; Gutman, F.; Collignon, M.-A.; Corone, C.; Pichon, M.-F.; Pecking, A.-P. 2005: FDG (18 fluorodeoxyglucose) positron emission tomography and breast cancer. Bulletin de l'Academie Nationale de Medecine 189(5): 963
Smith, G.T..; Hubner, K.F..; Legendre, A.M..; Matwichuk, C.L..; Daniel, G.B.. 1998: FDG Accumulation in Disseminated Blastomyces Dermatitidis in a Dog. Clinical Positron Imaging: Official Journal of the Institute for Clinical P.E.T 1(4): 261
Joyce, J.M.; Degirmenci, B.; Jacobs, S.; McCook, B.; Avril, N. 2005: FDG PET CT assessment of treatment response after yttrium-90 ibritumomab tiuxetan radioimmunotherapy. Clinical Nuclear Medicine 30(8): 564-568
Yuh-Feng, T.; Chin-Chu, W.; Cheng-Tau, S.; Min-Tsung, T. 2005: FDG PET CT features of an intraabdominal gossypiboma. Clinical Nuclear Medicine 30(8): 561-563
Stahl, A.; Stollfuss, J.; Ott, K.; Wieder, H.; Fink, U.; Schwaiger, M.; Weber, W.A. 2005: FDG PET and CT in locally advanced adenocarcinomas of the distal oesophagus. Clinical relevance of a discordant PET finding. NUKLEARMEDIZIN. Nuclear Medicine 44(6): 249-255; Quiz N55-56
Williams, H.T.; Smith, S. 2005: FDG PET and SPECT of bone metastases in breast cancer. AJR. American journal of roentgenology 185(6): 1651-2; author reply 1652-3
Al-Nahhas, A.M. 2003: FDG PET and alternative imaging in the management of thyroid carcinoma. Nuclear Medicine Review. Central and Eastern Europe 6(2): 139-145
Yamaura, G.; Yoshioka, T.; Kubota, K.; Yamaguchi, K.; Iwata, R.; Abe, T.; Kitagawa, Y.; Kanamaru, R.; Fukuda, H.; Ishioka, C. 2004: FDG PET and gallium scintigraphy for diagnosis of an advanced jejunal adenocarcinoma with distant metastases. Clinical Nuclear Medicine 29(12): 825-827
Talbot, J.-N.ël.; Montravers, F.ço.; Grahek, D.; Kerrou, K.; Gutman, F.; Cailleux, N. 2006: FDG PET and its impact on patient's management in oncology. Presse Medicale 35(9 Part 2): 1339-1346
Scheidhauer, K.; Walter, C.; Seemann, M.D. 2004: FDG PET and other imaging modalities in the primary diagnosis of suspicious breast lesions. European Journal of Nuclear Medicine and Molecular Imaging 31(Suppl 1): S70-S79
Siggelkow, W.; Rath, W.; Buell, U.; Zimny, M. 2004: FDG PET and tumour markers in the diagnosis of recurrent and metastatic breast cancer. European Journal of Nuclear Medicine and Molecular Imaging 31(Suppl 1): S118-S124
Lin, E. 2006: FDG PET appearance of a postpartum uterus. Clinical Nuclear Medicine 31(3): 159-160
Van Campen, C.M.C.; Visser, F.C.; van der Weerdt, A.P.; Knaapen, P.; Comans, E.F.I.; Lammertsma, A.A.; de Cock, C.C.; Visser, C.A. 2007: FDG PET as a predictor of response to resynchronisation therapy in patients with ischaemic cardiomyopathy. European Journal of Nuclear Medicine and Molecular Imaging 34(3): 309-315
Mumme, T.; Cremerius, U.; Hermanns, B.; Neuss, M.; Müller-Rath, R.; Büll, U.; Wirtz, D.C. 2003: FDG PET as an early nuclear medical diagnostic tool for aseptic wear-induced loosening of hip joint endoprostheses--a report of two cases. Der Unfallchirurg 106(7): 592-599
Smith, G.T..; Hubner, K.F..; Peterson, A.; Hunter, K.; Neff, J. 1998: FDG PET for Evaluation of Bronchioloalveolar Cell Carcinoma (BAC) of the Lung. Clinical Positron Imaging: Official Journal of the Institute for Clinical P.E.T 1(4): 260